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A B S T R A C T
Background
The Seven Countries study in the 1960s showed that populations in the Mediterranean region experienced lower cardiovascular disease
(CVD) mortality probably as a result of different dietary patterns. Later observational studies have confirmed the benefits of adherence
to a Mediterranean dietary pattern on CVD risk factors. Clinical trial evidence is limited, and is mostly in secondary prevention.
Objectives
To determine the effectiveness of a Mediterranean dietary pattern for the primary prevention of CVD.
Search methods
We searched the following electronic databases: theCochraneCentral Register ofControlledTrials (CENTRAL, Issue 9 of 12, September
2012); MEDLINE (Ovid, 1946 to October week 1 2012); EMBASE (Ovid, 1980 to 2012 week 41); ISI Web of Science (1970 to 16
October 2012); Database of Abstracts of Reviews of Effects (DARE), Health Technology Assessment Database and Health Economics
Evaluations Database (Issue 3 of 12, September 2012). We searched trial registers and reference lists of reviews and applied no language
restrictions.
Selection criteria
We selected randomised controlled trials in healthy adults and adults at high risk of CVD. AMediterranean dietary pattern was defined
as comprising at least two of the following components: (1) high monounsaturated/saturated fat ratio, (2) low to moderate red wine
consumption, (3) high consumption of legumes, (4) high consumption of grains and cereals, (5) high consumption of fruits and
vegetables, (6) low consumption of meat and meat products and increased consumption of fish, and (7) moderate consumption of
milk and dairy products. The comparison group received either no intervention or minimal intervention. Outcomes included clinical
events and CVD risk factors.
Data collection and analysis
Two review authors independently extracted data and contacted chief investigators to request additional relevant information.
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Main results
We included 11 trials (15 papers) (52,044 participants randomised). Trials were heterogeneous in the participants recruited, in the
number of dietary components and follow-up periods. Seven trials described the intervention as a Mediterranean diet. Clinical events
were reported in only one trial (Women’s Health Initiative 48,835 postmenopausal women, intervention not described as a Mediter-
ranean diet but increased fruit and vegetable and cereal intake) where no statistically significant effects of the intervention were seen
on fatal and non-fatal endpoints at eight years. Small reductions in total cholesterol (-0.16 mmol/L, 95% confidence interval (CI) -
0.26 to -0.06; random-effects model) and low-density lipoprotein (LDL) cholesterol (-0.07 mmol/L, 95% CI -0.13 to -0.01) were seen
with the intervention. Subgroup analyses revealed statistically significant greater reductions in total cholesterol in those trials describing
the intervention as a Mediterranean diet (-0.23 mmol/L, 95% CI -0.27 to -0.2) compared with control (-0.06 mmol/L, 95% CI -
0.13 to 0.01). Heterogeneity precluded meta-analyses for other outcomes. Reductions in blood pressure were seen in three of five trials
reporting this outcome. None of the trials reported adverse events.
Authors’ conclusions
The limited evidence to date suggests some favourable effects on cardiovascular risk factors.More comprehensive interventions describing
themselves as the Mediterranean diet may produce more beneficial effects on lipid levels than those interventions with fewer dietary
components. More trials are needed to examine the impact of heterogeneity of both participants and the intervention on outcomes.
P L A I N L A N G U A G E S U M M A R Y
Mediterranean diet for the prevention of cardiovascular disease
It is well established that diet plays a major role in cardiovascular disease risk. The traditional Mediterranean dietary pattern is of
particular interest because of observations from the 1960s that populations in countries of the Mediterranean region, such as Greece
and Italy, had lower mortality from cardiovascular disease compared with northern European populations or the US, probably as a
result of different eating habits.
This review assessed the effects of providing dietary advice to follow a Mediterranean-style dietary pattern to healthy adults or people at
increased risk of cardiovascular disease in order to prevent the occurrence of cardiovascular disease and reduce the risk factors associated
with it. Definitions of a Mediterranean dietary pattern vary and we included only randomised controlled trials (RCTs) of interventions
that reported at least two of the following components: (1) high monounsaturated/saturated fat ratio, (2) low to moderate red wine
consumption, (3) high consumption of legumes, (4) high consumption of grains and cereals, (5) high consumption of fruits and
vegetables, (6) low consumption of meat and meat products and increased consumption of fish, and (7) moderate consumption of milk
and dairy products. The control group was no intervention or minimal intervention. We found 11 RCTs (15 papers) that met these
criteria. The trials varied enormously in the participants recruited and the different dietary interventions. Four trials were conducted in
women only, two trials were in men only and the remaining five were in both men and women. Five trials were conducted in healthy
individuals and six trials were in people at increased risk of cardiovascular disease or cancer. The number of components relevant to a
Mediterranean dietary pattern ranged from two to five and only seven trials described the intervention as a Mediterranean diet.
The largest trial, which recruited only postmenopausal women and was not described as a Mediterranean diet meeting only two of the
criteria described above, reported no difference in the occurrence of cardiovascular disease between the dietary advice group and the
control group. The other trials measured risk factors for cardiovascular disease. As the studies were so different, it was not possible to
combine studies for most of the outcomes. Where it was possible to combine studies, we found small reductions in total cholesterol
levels as well as in the harmful low-density lipoprotein (LDL) cholesterol concentrations. The reductions in total cholesterol were
greater in the studies that described themselves as providing a Mediterranean diet. None of the trials reported side effects.
The review concludes that, from the limited evidence to date, a Mediterranean dietary pattern reduces some cardiovascular risk factors.
However, more trials are needed to look at the effects of the different participants recruited and the different dietary interventions to
see which interventions might work best in different populations.
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B A C K G R O U N D
Description of the condition
Cardiovascular disease (CVD) is one of the leading causes of death
worldwide (WHO 2011a). In 2008, it accounted for 30% of to-
tal global deaths, including 6.2 million deaths due to stroke and
7.2 million due to coronary heart disease (CHD) (WHO 2011a).
The burden of CVD also varies considerably between regions
(Müller-Nordhorn 2008; Reddy 1998). Within Europe, there is
a northeast to southwest gradient in mortality from ischaemic
heart disease where mortality rates are higher in counties within
Eastern Europe. The highest age-adjusted standardised mortality
rates (SMR) are found in Latvia (SMR 461), Estonia (SMR 446),
Slovakia (SMR 369) and Lithuania (SMR 357), while the lowest
rates are found in France (SMR 65), Portugal (SMR 87), Italy
(SMR 92) and Spain (SMR 92) (Müller-Nordhorn 2008). More
globally, while reductions in CVD mortality have been observed
in developed countries, there are increases in CVD mortality in
developing countries (Reddy 1998). TheWorld Health Organiza-
tion state that over 80% of CVD deaths occur in low- and middle-
income countries and the number of CVD deaths will increase
to 23.3 million by 2030, with CVD remaining the single leading
cause of death (Mathers 2006; WHO 2011b).
There is a longstanding recognition that diet plays a major role
in the aetiology of many chronic diseases, thereby contributing to
a significant geographical variability in morbidity and mortality
rates from chronic disease across different countries and popula-
tions worldwide (WHO 2003). In particular, early data from the
Seven Countries study in the 1960s showed that populations in
countries of the Mediterranean region, such as Greece and Italy,
experienced lower mortality from CVD compared with north-
ern European populations such as Finland or the US, probably
as a result of different dietary patterns (Keys 1986). Thereafter,
the potential beneficial effects of the Mediterranean dietary pat-
tern on longevity and health outcomes have become a source of
much interest and investigation. Several observational studies have
shown greater longevity and quality of life, as well as reduced mor-
tality and morbidity from CVD, cancer and other nutrition-re-
lated diseases with greater adherence to a Mediterranean dietary
pattern (Benetou 2008; Buckland 2009; Feart 2009; Fung 2009;
Knoops 2004; Lagiou 2006; Mitrou 2007; Trichopoulou 1995;
Trichopoulou 2003; Trichopoulou 2007). For example, findings
from the Spanish European Prospective Investigation into Can-
cer and Nutrition (EPIC) cohort study showed that a 1-unit in-
crease in Mediterranean diet score (scale from 0 to 18 units) was
associated with a 6% reduced risk of CHD, with similar risk es-
timates by sex (Buckland 2009). Systematic reviews of observa-
tional prospective studies have confirmed that greater adherence to
a Mediterranean diet is associated with a significant improvement
in health status and a significant reduction in overall mortality, as
well as in morbidity and mortality from CVD and other major
chronic diseases (Sofi 2008; Sofi 2010). Specifically, in the latest
published meta-analysis of prospective cohort studies, a 2-point
increase (scale from 0 to 7-9 points) in adherence to a Mediter-
ranean dietary pattern was associated with an 8% reduction in all-
cause mortality and a 10% reduction in CVD incidence or mor-
tality (Sofi 2010).
Furthermore, the Mediterranean diet has been associated with
favourable effects on major CVD risk factors. For example, stud-
ies have documented a decreased incidence of hypertension, dia-
betes mellitus and metabolic syndrome as a whole with a greater
adherence to a Mediterranean dietary pattern (Martnez-Gonzalez
2008;Nunez-Cordoba 2009; Psaltopoulou 2004; Rumawas 2009;
Sánchez-Taínta 2008). These findings have been corroborated by
systematic reviews supporting beneficial effects of the Mediter-
ranean diet onmetabolic syndrome and its individual components
(Buckland 2008; Kastorini 2011).
Against this large body of epidemiological observational studies,
there is less evidence from well-conducted and adequately pow-
ered randomised controlled trials (RCTs), especially with regard
to the potential efficacy of the Mediterranean diet in the primary
prevention of CVD (Serra-Majem 2006). Most of the RCTs have
addressed the effect of a Mediterranean type of diet on the occur-
rence of complications and recurrent events in people with exist-
ing CVD, showing favourable effects in CVD secondary preven-
tion (Barzi 2003; de Lorgeril 1994; de Lorgeril 1996; de Lorgeril
1999). There is also considerable variability in the definition of,
and duration of, the interventions evaluated.
Description of the intervention
The Mediterranean diet has been defined (Helsing 1989; Nestle
1995; Serra-Majem 1993; Willett 1995), and includes the follow-
ing dietary factors: a high intake of plant foods comprising mainly
fruits and vegetables, cereals and whole-grain breads, beans, nuts
and seeds; locally grown, fresh and seasonal, unprocessed foods;
large quantities of fresh fruit consumed daily whereas concentrated
sugars or honey are consumed a few times per week in smaller
quantities; olive oil as a main cooking ingredient and source of
fat; low to moderate amounts of cheese and yogurt; low quantities
of red meat and higher quantities of fish; and low to moderate
amounts of red wine often accompanying main meals. The orig-
inal Mediterranean type of diet reflects the common dietary pat-
tern of communities in countries of the Mediterranean region in
the early 1960s (Keys 1986), which was an expression of common
cultural and historical roots, and a shared set of lifestyle and eating
habits rather than amere assortment of specific micro- and macro-
nutrients (Trichopoulou 1997).
The intervention under investigation for the current review was
dietary advice to follow aMediterranean-style diet or a provision of
foods relevant to theMediterranean diet. At least two components
from the following list were required to reach our definition of a
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Mediterranean-style dietary pattern (Helsing 1989; Nestle 1995;
Serra-Majem 1993; Willett 1995):
1. high monounsaturated/saturated fat ratio (use of olive oil as
main cooking ingredient);
2. low to moderate red wine consumption;
3. high consumption of legumes;
4. high consumption of grains and cereals;
5. high consumption of fruits and vegetables;
6. low consumption of meat and meat products and increased
consumption of fish;
7. moderate consumption of milk and dairy products.
We chose at least two of the above components as our definition
of a Mediterranean-style dietary pattern as one component does
not constitute a dietary pattern.
How the intervention might work
There is a large quantity of observational and experimental ev-
idence supporting potential mechanisms to explain the benefi-
cial effect of the Mediterranean diet on cardiovascular health
(Serra-Majem 2006). For example, there is evidence of favourable
effects of the Mediterranean diet on insulin resistance and en-
dothelium-dependent vasoreactivity, as well as of the antioxidant
and anti-inflammatory effects of theMediterranean diet and its in-
dividual components such as fruits and vegetables, olive oil, whole
grains, fish and red wine (Chrysohoou 2004; Dai 2008; Pitsavos
2005; Ryan 2000). In addition, theMediterranean dietary pattern
has been associated with beneficial effects on many cardiovascular
risk factors, including lipoproteins, obesity, diabetes mellitus and
hypertension (Buckland 2008; Kastorini 2011;Martnez-Gonzalez
2008;Nunez-Cordoba 2009; Psaltopoulou 2004; Rumawas 2009;
Sánchez-Taínta 2008). There is additionally a large body of con-
sistent epidemiological evidence supporting the notion that light
to moderate red wine intake (one or two drinks/day), and moder-
ate alcohol consumption in general, is associated with reduced all-
cause and cardiovascular mortality and morbidity, and has bene-
ficial effects on cardiovascular risk factors, when compared with
both abstention and heavy drinking (Brien 2011; Corrao 2000;
Di Castelnuovo 2002; Di Castelnuovo 2006; Ronksley 2011).
In contrast, excess alcohol consumption is associated with an in-
creased risk of cardiovascular mortality and morbidity, primarily
through an increased risk of hypertension and stroke (Stranges
2004; Taylor 2009).
Why it is important to do this review
Modification of dietary factors forms an integral part of the pri-
mary prevention of CVD disease. A Mediterranean-style dietary
pattern is likely to produce a beneficial effect on the occurrence of
several chronic diseases, primarily CVD, which are closely linked
to lifestyle and eatinghabits. This notion is corroborated by dietary
recommendations of several scientific associations for the preven-
tion of major chronic disease (AHA 2006; WHO 2003). To our
knowledge, there have been no systematic reviews conducted to
examine the effectiveness of the Mediterranean dietary pattern in
the primary prevention of CVD.Most of the randomised evidence
has addressed the effect of a Mediterranean type of diet on the
occurrence of complications and recurrent events in people with
existing CVD, rather than in the primary prevention setting (Barzi
2003; de Lorgeril 1994; de Lorgeril 1999; Serra-Majem 2006).
There is also a wide degree of heterogeneity in the definition and
duration of the intervention.
O B J E C T I V E S
To determine the effectiveness of dietary advice to follow a
Mediterranean-style dietary pattern or the provision of foods rel-
evant to the Mediterranean diet for the primary prevention of
CVD.
M E T H O D S
Criteria for considering studies for this review
Types of studies
RCTs
Types of participants
Adults of all ages (18 years or more) from the general population
and those at high risk of CVD. The review focused on the effects
of a Mediterranean dietary pattern for the primary prevention of
CVD. Therefore, we excluded studies where more than 25% of
participants had CVD at baseline including people who had ex-
perienced a previous myocardial infarction (MI), stroke, revascu-
larisation procedure (coronary artery bypass grafting (CABG) or
percutaneous transluminal coronary angioplasty (PTCA)), people
with angina, or angiographically defined CHD, cerebrovascular
disease (stroke) and peripheral arterial disease. We also excluded
studies where more than 25% of the participants had type 2 di-
abetes as while patients with type 2 diabetes are at increased risk
of CVD, interventions for diabetes are covered specifically by the
Cochrane Metabolic and Endocrine Disorders review group.
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Types of interventions
The intervention was specific dietary advice to follow a Mediter-
ranean-style dietary pattern or provision of dietary factors rele-
vant to theMediterranean diet. At least two components from the
following list were required to meet our definition of a Mediter-
ranean-style diet (Helsing 1989; Nestle 1995; Serra-Majem 1993;
Willett 1995).
1. High monounsaturated/saturated fat ratio (use of olive oil
as main cooking ingredient).
2. Low to moderate red wine consumption.
3. High consumption of legumes.
4. High consumption of grains and cereals.
5. High consumption of fruits and vegetables.
6. Low consumption of meat and meat products and increased
consumption of fish.
7. Moderate consumption of milk and dairy products.
We intended to consider studies examining dietary advice to fol-
low a Mediterranean-style diet separately from studies examining
the provision of foods, but, for all studies that met our inclusion
criteria, the intervention was dietary advice. It was also our in-
tention to stratify results according to the number of components
constituting the Mediterranean dietary pattern, the intensity and
duration of the intervention and follow-up period, and the ef-
fects of age and gender. However, there were insufficient trials
that met the inclusion criteria to perform these analyses. We did
consider interventions describing themselves as a Mediterranean
diet or style of diet including the core components of increased
fruit and vegetable consumption and exchange of saturated fat for
monounsaturated fat, compared with other interventions that met
our criteria, in subgroup analyses.
We focused on follow-up periods of three months or more. We
only considered trials where the comparison group was no inter-
vention or minimal intervention (e.g. leaflet to follow a dietary
pattern with no person-to-person intervention or reinforcement).
The rationale for this was to determine the effects of a Mediter-
ranean dietary pattern more clearly rather than to include other
dietary interventions as comparison groups. We did not exclude
studies where loss to follow-up was greater than 20%, but we car-
ried out sensitivity analyses to examine the effect of excluding these
studies on the overall effect estimate.
Types of outcome measures
Endpoints were measured using validated measures.
Primary outcomes
1. Cardiovascular mortality.
2. All-cause mortality.
3. Non-fatal endpoints such as MI, CABG, PTCA, angina, or
angiographically defined CHD, stroke, carotid endarterectomy
or peripheral arterial disease (PAD).
Secondary outcomes
1. Changes in blood lipids (total cholesterol, high-density
lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL)
cholesterol, triglycerides), and blood pressure (systolic and
diastolic blood pressure).
2. Occurrence of type 2 diabetes as a major CVD risk factor.
3. Health-related quality of life.
4. Adverse effects (as defined by the authors of the included
trials).
5. Costs.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases:
• Cochrane Central Register of Controlled Trials
(CENTRAL, Issue 9 of 12, September 2012);
• MEDLINE (Ovid, 1946 to October week 1 2012);
• EMBASE (Ovid, 1980 to 2012 week 41);
• ISI Web of Science (1970 to 16 October 2012);
• Database of Abstracts of Reviews of Effects (DARE),
Health Technology Assessment Database and Health Economic
Evaluations Database (Issue 3 of 12, September 2012).
We used medical subject headings (MeSH) or equivalent and text
word terms and the Cochrane sensitive-maximising RCT filter for
MEDLINE (Lefebvre 2011), and adaptations of it for EMBASE
and Web of Science. We applied no language restrictions. We
tailored searches to individual databases (Appendix 1).
Searching other resources
In addition, we checked reference lists of reviews for additional
studies.
We searched the metaRegister of con-
trolled trials (mRCT) (www.controlled-trials.com/mrct), Clini-
caltrials.gov (www.clinicaltrials.gov) and the World Health Orga-
nization (WHO) International Clinical Trials Registry Platform
(ICTRP) (apps.who.int/trialsearch/) for ongoing trials.
We contacted authors where necessary for additional information.
Data collection and analysis
Selection of studies
From the searches, two review authors (KR, LH or NF) reviewed
the title and abstract of each paper and retrieved potentially rele-
vant references. Following this initial screening, we obtained the
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full-text reports of potentially relevant studies, and two review au-
thors (KR, LH or NF) independently selected studies to be in-
cluded in the review using predetermined inclusion criteria. In all
cases, we resolved disagreements about any study inclusions by
consensus and consulted a third review author (MT) if disagree-
ment persisted.
Data extraction and management
Two review authors (KR, LH or NF) independently extracted data
using a proforma, and contacted chief investigators to request ad-
ditional relevant information if necessary. We extracted details of
the study design, participant characteristics, study setting, inter-
vention (including number of components and duration), and
outcome data including details of outcome assessment, adverse
effects, and methodological quality (randomisation, blinding, at-
trition) from each of the included studies. We resolved disagree-
ments about extracted data by consensus.
Assessment of risk of bias in included studies
We assessed risk of bias by examining the quality of the ran-
dom sequence generation and allocation concealment, description
of dropouts and withdrawals (including analysis by intention to
treat (ITT)), blinding (participants, personnel and outcome as-
sessment) and selective outcome reporting (Higgins 2011). Two
review authors (KR, LH or NF) independently assessed the risk
of bias of included studies and rated each domain as having a ’low
risk of bias’, a ’high risk of bias’ or an ’unclear risk of bias’.
Measures of treatment effect
We processed data in accordance with the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2011). We expressed
dichotomous outcomes (available for only one trial) as hazard ra-
tios (HR) with 95% confidence intervals (CI). For continuous
variables, we compared net changes (i.e. intervention group minus
control group differences) and calculated mean differences (MD)
and 95% CIs for each study.
Assessment of heterogeneity
For each outcome, we carried out tests of heterogeneity (using the
Chi2 test of heterogeneity and the I2 statistic). In the situation of
no heterogeneity, we performed a fixed-effect meta-analysis. If we
detected substantial heterogeneity, we looked for possible expla-
nations for this (e.g. participants and intervention). If we could
not explain the heterogeneity, the review authors considered the
following options: provide a narrative overview and not aggregate
the studies at all, or use a random-effects model with appropriate
cautious interpretation.
Subgroup analysis and investigation of heterogeneity
It was our intention to report the results separately for dietary
advice to follow a Mediterranean dietary pattern and provision of
foods relevant to a Mediterranean-style diet. However, to date we
have found only trials of dietary advice to follow a Mediterranean
dietary pattern. If there were sufficient trials that met the inclusion
criteria it was also our intention to examine the impact of the
number of components of the Mediterranean dietary pattern, the
intensity and duration of the intervention, the follow-up period,
and the effects of gender and age. We have performed subgroup
analyses to examine the effect of interventions described as the
Mediterranean diet or style of diet or those including both of the
core components of increased fruit and vegetable consumption
and exchange of saturated fat for monounsaturated fat, compared
with other interventions meeting our criteria.
Sensitivity analysis
If there had been sufficient trials that met the inclusion criteria, it
was our intention to perform sensitivity analyses excluding studies
of lowmethodological quality and undertake funnel plots and tests
of asymmetry to assess possible publication bias (Egger 1997). We
did perform sensitivity analyses excluding studies where loss to
follow-up exceeded 20%.
R E S U L T S
Description of studies
Results of the search
The database searches generated 13,406 hits and 10,680 after de-
duplication. We identified two additional records by searching
other resources. Screening the titles and abstracts of the 10,682
records identified 249 papers for formal inclusion or exclusion.
Of these, 11 RCTs (15 papers) met the inclusion criteria. We
identified one ongoing trial and one trial is awaiting classification.
The flow of studies throughout the review is presented in the
PRISMA diagram in Figure 1.
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Figure 1. Study flow diagram.
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Included studies
Details of the methods, participants, intervention, comparison
group andoutcomemeasures for each of the studies included in the
review are shown in the Characteristics of included studies table.
Eleven trials (15 papers) were included with 52,044 participants
randomised. The majority of participants were enrolled in one
large multicentre trial (48,835 women; WHI)
The health status of participants varied between studies. The
majority of participants (49,185 randomised) were classified as
healthy and were recruited by five of the trials (Abedi 2010;
Castagnetta 2002; Djuric 2009; Konstantinidou 2010; WHI).
The remaining six trials recruited previously untreated hyper-
cholesteraemic participants (Jula 2002; Wardle 2000), elderly
participants with long-standing hypercholesterolaemia (Lindman
2004), overweight or obese participants with untreated hyper-
tension (ENCORE), sedentary people with metabolic syndrome
(Esposito 2004), and one trial recruited participants at high risk of
colorectal cancer (Lanza 2001). Three trials including the largest
trial recruited only women who were postmenopausal (Abedi
2010; Castagnetta 2002; WHI), and one trial recruited only
women aged 25 to 65 years (Djuric 2009). In contrast, two tri-
als recruited only men (Jula 2002; Lindman 2004), and the re-
maining five recruited bothmen andwomen (ENCORE; Esposito
2004; Konstantinidou 2010; Lanza 2001; Wardle 2000). The tri-
als were conducted in the US (Djuric 2009; ENCORE; Lanza
2001; WHI), Italy (Castagnetta 2002; Esposito 2004), Finland
(Jula 2002), Spain (Konstantinidou 2010), Norway (Lindman
2004), Iran ( Abedi 2010), and the UK (Wardle 2000), and the
duration of the intervention and follow-up periods varied from
three months (Jula 2002; Konstantinidou 2010; Wardle 2000 ),
four months (ENCORE), six months (Abedi 2010; Castagnetta
2002; Djuric 2009; Lindman 2004), two years (Esposito 2004),
four years (Lanza 2001), and up to eight years (WHI).
One trial had a dietary intervention that comprised five com-
ponents that met our definition of a Mediterranean-style diet
(see Types of interventions for list of components) (Castagnetta
2002), one trial had a dietary intervention that comprised four
components (ENCORE), five trials had dietary interventions
that comprised three components (Esposito 2004; Jula 2002;
Konstantinidou 2010; Lindman 2004; Wardle 2000). The re-
maining four trials had a dietary intervention comprising two com-
ponents (Abedi 2010; Djuric 2009; Lanza 2001;WHI). Seven tri-
als described the intervention as a Mediterranean diet or Mediter-
ranean-style diet (Castagnetta 2002; Djuric 2009; Esposito 2004;
Jula 2002; Konstantinidou 2010; Lindman 2004; Wardle 2000).
The remaining trials fulfilled our definition of two or more com-
ponents of the Mediterranean diet but did not include both of
the key components associated with the Mediterranean diet (in-
creasing fruit and vegetable intake and exchanging saturated fat
for monounsaturated fat) (Abedi 2010; ENCORE; Lanza 2001;
WHI).
We identified one ongoing trial (Sanders 2012) (seeCharacteristics
of ongoing studies table). Briefly, this trial examines the effects
of a cardioprotective diet (decreased salt and saturated fatty acids
intake, and increased whole grain cereals, fruit and vegetables and
oily fish intake) with a control diet (average UK diet), in healthy
men and women, for a period of three months. The outcomes
measured include systolic blood pressure and lipid levels. The an-
ticipated end date for this trial was December 2012.
One study is awaiting classification (Inguaggiato 2011) (see
Characteristics of studies awaiting classification table).
Excluded studies
Details and reasons for exclusion for the studies that most closely
missed the inclusion criteria are presented in the Characteristics
of excluded studies table. Reasons for exclusion for the majority
of studies was due to the control group not being minimal (e.g.
receiving face-to-face dietary advice) and studies not being RCTs.
Risk of bias in included studies
Details are provided for each of the included studies in the ’Risk
of bias’ section of the Characteristics of included studies table. We
assessed risk of bias as ’low’, ’high’ or ’unclear’.
Allocation
Themethods of random sequence generationwere unclear in seven
of the 11 included studies (Abedi 2010; Castagnetta 2002; Djuric
2009; Jula 2002; Lanza 2001; Lindman 2004; Wardle 2000). In
the four studieswhere thiswas clear, we judged themethods used to
be of low risk of bias (ENCORE; Esposito 2004; Konstantinidou
2010;WHI). Themethods of allocation concealmentwere unclear
in eight of the 11 included studies.Where this was clear, we judged
the methods used to be at low risk of bias (ENCORE; Esposito
2004; Wardle 2000).
Blinding
The blinding of participants and personnel was unclear in all 11
trials. However, the blinding of participants and personnel for be-
havioural interventions is difficult, if not impossible, inmost cases.
Blinding of outcome assessment was unclear in seven of the 11 tri-
als (Abedi 2010; Castagnetta 2002; Djuric 2009; Konstantinidou
2010; Lanza 2001; Lindman 2004; Wardle 2000). In the remain-
ing four trials, outcome assessments were made blind to the group
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assignment and were judged to be at low risk of bias (ENCORE;
Esposito 2004; Jula 2002; WHI).
Incomplete outcome data
We judged four of the 11 trials to be of low risk of bias as rea-
sons for exclusions and loss-to-follow-up were provided or ITT
analyses were performed, or both (ENCORE; Esposito 2004;
Konstantinidou 2010; WHI). We judged three studies to be at
high risk of bias as no reasons were provided for excluded par-
ticipants (Jula 2002), and there was differential loss to follow-up
that exceeded 20% in the control group in one trial (Abedi 2010),
and in the intervention group in another trial (Djuric 2009). We
examined the exclusion of these two trials in sensitivity analyses.
For the remaining trials, we judged the risk of bias as unclear.
Selective reporting
For four of the studies, the risk of bias associated with selective re-
portingwas unclear (Castagnetta 2002; Jula 2002;Konstantinidou
2010; Lindman 2004), the remaining seven studies clearly stated
the primary and secondary outcomes and reported the results for
these.
Other potential sources of bias
There was insufficient information to judge the risk of bias in other
sources of bias not covered above and we categorised all studies as
unclear.
Effects of interventions
Clinical events
The largest trial had long-term follow-up of eight years andwas the
only trial reporting clinical events (WHI). In participants without
a history of CVD (3.4% had CVD at baseline), there were no
statistically significant effects of the dietary intervention on non-
fatal MI (HR 0.91, 95% CI 0.8 to 1.04), CHD death (HR 1.01,
95% CI 0.81 to 1.27), revascularisation (HR 0.91, 95% CI 0.82
to 1.01), fatal stroke (HR 0.94, 95% CI 0.65 to 1.35), non-fatal
stroke (HR 1.04, 95% CI 0.90 to 1.19) and total CVD events
(clinical MI, silent MI, death due to CHD, CABG/percutaneous
coronary intervention and stroke) (HR 0.96, 95% CI 0.89 to
1.03). The WHI trial was not described as a Mediterranean-style
diet neither did it comprise of both an increase in fruit and veg-
etable consumption and exchanging saturated fat for monounsat-
urated fat. It met our inclusion criteria of two components that
included increasing fruit and vegetable and cereal and grain intake.
None of the studies describing their interventions as a Mediter-
ranean diet reported clinical events.
Cardiovascular risk factors
Lipid levels
Total cholesterol
Eight trials (4151 participants randomised) measured total choles-
terol levels and reported data that could be used in meta-
analyses (Abedi 2010; Djuric 2009; ENCORE; Esposito 2004;
Konstantinidou 2010; Lanza 2001; Wardle 2000; WHI). Lipid
levels were measured in only a subgroup (n = 2816) of the large
WHI trial (WHI). There was significant heterogeneity between
trials (I2 = 74%). Pooling the studies resulted in similar estimates
for both fixed-effect and random-effects models indicating that
there was no strong evidence of small study effects, so we reported
the random-effects model, with appropriate cautious interpreta-
tion. The dietary intervention reduced total cholesterol levels by
0.16 mmol/L (95% CI 0.06 to 0.26; random-effects model, P
value = 0.003; Analysis 1.1). Two of the trials were at high risk of
bias as there was differential loss to follow-up that just exceeded
20% in the control group (Abedi 2010), and intervention group
(Djuric 2009), of each trial. Sensitivity analyses excluding these
two trials produced a similar effect estimate (MD -0.18, 95% CI
-0.28 to -0.07).
Two further trials measured total cholesterol but did not provide
data in a useable format for meta-analyses despite our efforts to
obtain these (Castagnetta 2002; Jula 2002). Both trials reported
significant reductions in total cholesterol levels with the dietary
intervention.
We performed subgroup analyses to examine the effect of inter-
ventions described as aMediterranean or Mediterranean-style diet
and those that comprised at least two components but did not
comprise both of the core components of increasing fruit and veg-
etable intake and exchanging saturated fat for monounsaturated
fat. The reduction in total cholesterol was statistically significantly
greater for interventions describing themselves as a Mediterranean
diet (MD 0.23, 95% CI -0.27 to -0.2) compared with those that
did not (MD -0.06, 95% CI -0.13 to 0.01; Analysis 1.2).
Low-density lipoprotein cholesterol
Six trials (3227 participants randomised) measured LDL-choles-
terol and provided data that could be pooled in a meta-analy-
sis (Abedi 2010; Djuric 2009; ENCORE; Konstantinidou 2010;
Wardle 2000; WHI). Heterogeneity was low to moderate (I2 =
22%) and we performed a fixed-effect meta-analysis. There was
a small but statistically significant reduction in LDL-cholesterol
(MD -0.07 mmol/L, 95% CI -0.13 to -0.01) with the dietary in-
tervention, and results were dominated by the largest trial (WHI)
(Analysis 1.3). Two of the trials were at high risk of bias as there was
differential loss to follow-up that just exceeded 20% in the con-
trol group (Abedi 2010) and intervention group (Djuric 2009) of
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each trial. Sensitivity analyses excluding these two trials produced
a similar effect estimate (MD -0.08, 95% CI -0.14 to -0.02).
A further trial reported LDL-cholesterol but did not report follow-
up data and attempts to retrieve this were unsuccessful (Jula 2002).
This trial reported a statistically significant reduction in LDL-
cholesterol of 10.8% with the intervention.
We performed subgroup analyses to examine the effect of interven-
tions describing themselves as a Mediterranean or Mediterranean-
style diet and those that comprised at least two components but
did not comprise both of the core components of increasing fruit
and vegetable intake and exchanging saturated fat for monoun-
saturated fat. The reduction in LDL-cholesterol was greater for
interventions describing themselves as a Mediterranean diet (MD
-0.16, 95% CI -0.39 to 0.07; random-effects model) compared
with those that did not (MD -0.06, 95% CI -0.12 to 0.00; ran-
dom-effects model), but this did not reach statistical significance
(Analysis 1.4).
High-density lipoprotein cholesterol
Eight trials measured the effect of the diet on HDL-cholesterol
(Abedi 2010; Djuric 2009; ENCORE; Esposito 2004; Jula 2002;
Konstantinidou 2010;Wardle 2000;WHI, 3527 participants ran-
domised) but we could not obtain follow-up data from one of the
authors (Jula 2002). There was significant heterogeneity between
the remaining seven trials (I2 = 83%) and so we did not perform a
meta-analysis. One trial reported a statistically significant increase
in HDL-cholesterol levels with the intervention (MD 0.08 mmol/
L, 95% CI 0.06 to 0.09) (Esposito 2004). The remaining six tri-
als found no effect of the intervention on HDL-cholesterol levels
(MD 0.01 mmol/L, 95% CI -0.08 to 0.1 (Abedi 2010); MD 0.03
mmol/L, 95% CI -0.15 to 0.2 (Djuric 2009); MD -0.04 mmol/L,
95% CI -0.17 to 0.09 (ENCORE); MD 0.00 mmol/L, 95% CI -
0.08 to 0.08 (Konstantinidou 2010); MD -0.06 mmol/L, 95%CI
-0.18 to 0.06 (Wardle 2000); MD -0.01 mmol/L, 95% CI -0.03
to 0.02 (WHI)). The study that did not provide follow-up data
reported a statistically significant reduction in HDL-cholesterol
of 4.9% (Jula 2002).
Triglycerides
Nine trials measured triglyceride levels (Abedi 2010; Djuric 2009;
ENCORE; Esposito 2004; Jula 2002; Konstantinidou 2010;
Lindman 2004; Wardle 2000; WHI, 3626 participants ran-
domised). Two of the trials provided postintervention values as
medians (with 25th and 75th percentiles) andwere not included in
the analysis (Konstantinidou 2010; Lindman 2004) and one trial
did not report follow-up data (Jula 2002). There was significant
heterogeneity between the remaining six trials (I2 = 94%) and so
we did not perform ameta-analysis. There was a statistically signif-
icant reduction in triglyceride levels with the intervention in one
trial (MD -0.21, 95% CI -0.23 to -0.19; Esposito 2004). In four
trials, the dietary intervention showed no effect on triglyceride
levels (MD -0.05 mmol/L, 95% CI -0.49 to 0.39 (Abedi 2010);
MD 0.00 mmol/L, 95% CI -0.23 to 0.23 (Djuric 2009); MD -
0.01 mmol/L, 95%CI -0.24 to 0.22 (ENCORE);MD0.00, 95%
CI -0.05 to 0.05 (WHI)). In the remaining trial, the dietary inter-
vention produced a statistically significant increase in triglyceride
levels (MD 0.36 mmol/L, 95% CI 0.15 to 0.57; Wardle 2000). In
the two trials reporting medians, no effect of the diet on triglyc-
eride levels was observed (Konstantinidou 2010; Lindman 2004).
Similarly, in the study where no follow-up data were reported, no
effect of the diet on triglyceride levels was seen (Jula 2002).
Blood pressure
Five trials measured systolic and diastolic blood pressure (Abedi
2010; ENCORE; Esposito 2004; Konstantinidou 2010; WHI,
42,724 participants randomised). Substantial heterogeneity ex-
isted between the trials for both outcomes (I2 = 94% and 93%,
respectively), and differences were observed between fixed- and
random-effects models suggesting small trial effects, so we did not
perform meta-analyses. A statistically significant reduction in sys-
tolic blood pressure was observed in three of the trials (MD -7.8
mmHg, 95% CI -12.11 to -3.49 (ENCORE); MD -3.00 mmHg,
95% CI -3.46 to -2.54 (Esposito 2004); MD -0.70 mmHg, 95%
CI -1.03 to -0.37 (WHI)). The remaining two trials did not show a
statistically significant reduction in systolic blood pressure (Abedi
2010; Konstantinidou 2010). For diastolic blood pressure, a sta-
tistically significant reduction was observed in three of the tri-
als (MD -3.7 mmHg, 95% CI -6.1 to -1.3 (ENCORE); MD -
2.00 mmHg, 95% CI -2.29 to -1.71 (Esposito 2004); MD -0.70
mmHg, 95% CI -0.88 to -0.52 (WHI)). The remaining two trials
did not show a statistically significant reduction in diastolic blood
pressure (Abedi 2010; Konstantinidou 2010).
Type 2 diabetes
Incident-treated diabetes was reported during the eight years of
follow-up of the WHI trial (WHI). They found no statistically
significant difference in the diabetes risk between the intervention
and control group (HR 0.96, 95% CI 0.90 to 1.03).
Health-related quality of life, adverse effects or costs
None of the trials reported health-related quality of life, adverse
effects or costs.
There was significant heterogeneity in many of the outcomes and,
in most cases, a narrative synthesis was performed. The hetero-
geneity is probably due to the varying interventions with different
numbers of components relevant to the Mediterranean diet and
also the participants, both healthy populations and those at high
risk of CVD. It was our intention to explore this heterogeneity fur-
ther in stratified analyses but, to date, there are insufficient studies
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included in this review to do this. However, we will conduct this
in an update of this review when more evidence accrues.
D I S C U S S I O N
The aim of this review was to evaluate the effectiveness of dietary
advice to follow a Mediterranean-style diet or the provision of
foods relevant to the Mediterranean diet for the primary preven-
tion of CVD. We also examined the effects of a Mediterranean-
style diet on major cardiovascular risk factors including blood
lipids, blood pressure and occurrence of type 2 diabetes.
Summary of main results
Relatively few trials were included in this review, 11 completed
RCTs (15 papers) and one ongoing RCT met the inclusion crite-
ria of our definition of a Mediterranean dietary pattern. All trials
examined the effects of dietary advice to follow a Mediterranean-
style dietary pattern; none of the trials examined the effects of
provision of foods relevant to a Mediterranean diet. The number
of components of the Mediterranean diet varied from two to five,
and seven trials described the intervention as aMediterranean diet.
Only one trial, the largest with 48,835 postmenopausal women
randomised, reported clinical events and showed no statistically
significant effects of the intervention on both fatal and non-fa-
tal endpoints at eight years’ follow-up (WHI), and incident dia-
betes rates were also similar between the intervention and control
group for this trial. The WHI trial was not described as Mediter-
ranean diet and comprised only two of the components in our
definition (WHI). None of the studies describing the intervention
as a Mediterranean diet reported clinical events. Cardiovascular
risk factors were measured in all trials but heterogeneity between
trials precluded meta-analysis for some outcomes. Small reduc-
tions in total cholesterol and LDL-cholesterol occurred with the
dietary interventions where pooling was appropriate (total choles-
terol: MD -0.16 mmol/L, 95% CI -0.26 to -0.06, random-ef-
fects model; LDL-cholesterol: -0.07 mmol/L, 95% CI -0.13 to -
0.01, respectively). Subgroup analyses revealed larger reductions
in total cholesterol in those studies describing the intervention as
a Mediterranean diet (MD -0.23 mmol/L, 95% CI -0.27 to -0.2
versus -0.06 mmol/L, 95% CI -0.13 to 0.01; P value < 0.001).
Blood pressure was reduced in three of the five trials reporting
this outcome. None of the trials reported health-related quality of
life, adverse events or costs. There was significant heterogeneity
in the different dietary interventions both in terms of the num-
ber of components relevant to a Mediterranean dietary pattern,
intensity and duration, the participants recruited and the follow-
up periods. To date there are an insufficient number of trials to
perform stratified analyses to examine the effects of these further
on outcomes.
Overall completeness and applicability of
evidence
We included 11 trials (15 papers) with 52,044 participants ran-
domised. We also identified one ongoing trial (Sanders 2012).
However, only the largest trial (WHI), which recruited post-
menopausal women only (48,835 randomised), contributed data
to our primary outcomes of major CVD clinical endpoints.
Therefore, the applicability of these findings to the male pop-
ulation is uncertain, given the well-established differences in
cardio-metabolic risk factor profiles between women and men
(Mosca 2011). In addition, the intervention was not described
as a Mediterranean diet and satisfied only two components of a
Mediterranean dietary pattern.
There was also a large variation in the health status of par-
ticipants between studies. The majority of participants (49,185
randomised) were classified as healthy and were recruited by
five of the trials (Abedi 2010; Castagnetta 2002; Djuric 2009;
Konstantinidou 2010; WHI); most of these were in women. The
remaining six trials recruited high-risk individuals, that is hyper-
cholesteraemic participants (Jula 2002, Lindman 2004; Wardle
2000), overweight or obese participants with untreated hyperten-
sion (ENCORE), and sedentary people with metabolic syndrome
(Esposito 2004), and one trial recruited participants at high risk of
colorectal cancer (Lanza 2001). Hence, the applicability of these
findings to different population groups is uncertain. All trials were
conducted in developed countries and most in Western popula-
tions; therefore, the generalisability of these findings to lower-in-
come settings has to be confirmed.
The effectiveness of the provision of foods relevant to theMediter-
ranean diet could not be assessed, because all studies that met the
inclusion criteria were based on dietary advice to follow aMediter-
ranean-style diet. It was also our intention to stratify results accord-
ing to the number of components constituting the Mediterranean
dietary pattern and the intensity and duration of the intervention.
However, there was an insufficient number of trials that met the
inclusion criteria to perform these analyses. However, we did per-
form subgroup analyses to examine the effect of interventions de-
scribed as the Mediterranean diet with those that did not but met
our criteria of two or more components. We found greater reduc-
tions in total cholesterol for interventions describing themselves
as a Mediterranean diet that was statistically significant. A similar
trend was seen for LDL-cholesterol but few studies were included
in this analysis. Therefore, it seems that a more comprehensive
intervention such as those described as a Mediterranean diet tar-
geting several food groups simultaneously may be more effective
at least in reducing lipid levels.
The duration of the intervention and follow-up periods varied
widely across studies, ranging from short-term trials (three to six
months, Abedi 2010; Castagnetta 2002; Djuric 2009; ENCORE;
Jula 2002; Konstantinidou 2010; Lindman 2004; Wardle 2000)
to long-term interventions (two to eight years, Esposito 2004;
WHI). Both short- and long-term health effects of dietary in-
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terventions are plausible in terms of cardiovascular health, given
the relatively quick response of cardiovascular risk factors such as
blood lipids and blood pressure to lifestyle and dietary modifica-
tions (AHA 2006; Appel 1997; Appel 2001; Appel 2006). How-
ever, it is likely that potential beneficial effects of dietary inter-
ventions for the prevention of major chronic disease endpoints,
such as mortality, CVD and type 2 diabetes, should represent the
outcome of a long-term process linked to the interplay of dietary
patterns with genetic and environmental factors. In addition, the
sustainability of long-term lifestyle and dietary modifications is
challenging. Therefore, the public health relevance of trials with
extremely short-term dietary interventions or follow-up periods
in this context is questionable.
Quality of the evidence
Overall, the studies included in this review, especially the smaller
short-term trials, were at some risk of bias or there was insuffi-
cient information to judge the risk of bias; hence, results should be
treated with some caution. The methods of random sequence gen-
eration were unclear in seven of the 11 included studies, in the four
studies where this was clear, we judged the methods used to be of
low risk of bias (ENCORE; Esposito 2004; Konstantinidou 2010;
WHI). Similarly, the methods of allocation concealment were un-
clear in most of the included studies, and where this was clear,
we judged the methods used to be at low risk of bias (ENCORE;
Esposito 2004; Wardle 2000).
The blinding of participants andpersonnel was unclear in all 11 tri-
als but the blinding of participants and personnel for behavioural
interventions is difficult, if not impossible, in most cases. Blinding
of outcome assessment was also unclear in most trials, outcome
assessments were made blind to the group assignment in four trials
and we judged them to be at low risk of bias (ENCORE; Esposito
2004; Jula 2002; WHI).
We judged four of the 11 trials to be of low risk of attrition bias
as reasons for exclusions and loss-to-follow-up were provided or
ITT analyses were performed, or both (ENCORE; Esposito 2004;
Konstantinidou 2010; WHI). We judged three studies to be at
high risk of bias as no reasons were provided for excluded par-
ticipants (Jula 2002), and there was differential loss to follow-up
that exceeded 20% in two trials (Abedi 2010; Djuric 2009). We
examined the exclusion of these two trials in sensitivity analyses
but they did not impact significantly on the effect estimates for
either total cholesterol or LDL-cholesterol levels. For the remain-
ing trials, we judged the risk of bias as unclear.
We judged selective reporting to be at low risk of bias for the
majority of studies as the primary and secondary outcomes were
stated and results were reported for these. For four of the studies,
the risk of bias associated with selective reporting was unclear
(Castagnetta 2002; Jula 2002; Konstantinidou 2010; Lindman
2004). For all trials, there was insufficient information provided
to assess the risk of bias in other sources of bias not covered above.
Potential biases in the review process
There was a high degree of heterogeneity between trials, from
different sources (participants, nature andduration of intervention
and follow-up, outcome data), which precluded statistical pooling
for most outcomes.
The WHI was the largest trial included, the only study contribut-
ing data to our primary outcomes, and dominated findings of
this review (WHI). However, this study was based on a highly
selected group of participants (i.e. postmenopausal women aged
50 to 79 years), which makes the generalisability of these findings
uncertain. In fact, the possibility of different or greater effects by
dietary interventions of this nature among men or younger age
groups cannot be ruled out. Furthermore, a good proportion of
WHI participants were on cardiovascular medication at baseline
(approximately 12% on lipid-lowering medication, 18% on as-
pirin and 43% had treated hypertension or blood pressure ≥140/
90 mmHg), and some had prevalent CVD (3.4%). The distribu-
tion of cardiovascular medication was not different between in-
tervention and comparison groups at baseline and did not change
during the trial; however, this may have biased the results toward
null findings if CVD risk factors such as blood pressure and lipid
levels were optimally controlled prior to the intervention (bias
against seeing no effect of the intervention). Indeed, after exclud-
ing participants with baseline CVD, there was an apparent trend
toward small protective effects for CHD events in women with-
out baseline disease (WHI), although this did not reach statistical
significance. Finally, the WHI Dietary Modification Trial inter-
vention comprised only two components that met our definition
of a Mediterranean-style diet, and was not specifically tailored for
CVDprevention. However, it is plausible that more aggressive and
targeted dietary interventions are necessary to influence CVD risk
factors and, therefore, achieve a significant public health impact on
CVD events (AHA 2006; Appel 1997; Appel 2001; Appel 2006).
Our decision to restrict this review to interventions that only fo-
cused on the effectiveness of a Mediterranean dietary pattern per
se avoided the potential confounding effects of other behavioural
interventions on our outcomes, for example, those involving in-
creased exercise or weight loss in the context of multifactorial tri-
als. Also, our strict inclusion criteria, particularly with regard to
the comparison group, excluded a number of well-known trials,
such as the PREDIMED (Prevention with Mediterranean Diet)
trial in Spain (Estruch 2006; Estruch 2013) or the DASH (Di-
etary Approaches to Stop Hypertension) trials (Appel 1997; Appel
2001; Appel 2006), where the control groups were not minimal.
Our decision to exclude trials in people with diabetes who are
at increased risk for CVD may also have missed relevant stud-
ies, but interventions for the management of diabetes are cov-
ered by the Cochrane Metabolic and Endocrine Disorders Group,
and are not within the remit of the Cochrane Heart Group. Fi-
nally, the definition of the Mediterranean dietary pattern is not
homogeneous, andmay vary across different geographical and cul-
tural contexts (Helsing 1989; Nestle 1995; Serra-Majem 1993;
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Serra-Majem2006;Willett 1995). The result of this potential mis-
classification would probably be to underestimate the true effect
of the dietary intervention on the selected outcomes (Copeland
1977). Our choice to use a classification system rather than in-
clude only those studies describing the intervention as a Mediter-
ranean diet attempted to address this heterogeneity, and given
sufficient studies would allow further exploration of active com-
ponents. The components required to meet our definition of a
Mediterranean dietary pattern were based on previous definitions
(Helsing 1989; Nestle 1995; Serra-Majem 1993; Serra-Majem
2006; Willett 1995), and two or more components were required
to meet our inclusion criteria. However, this definition resulted in
the inclusion of several trials whose interventions included advice
to follow a low-fat diet (ENCORE; Lanza 2001; WHI), which
does not constitute a Mediterranean dietary pattern, in addition
to at least two other relevant components. Given the view that the
original Mediterranean type of diet was an expression of common
cultural and historical roots, and a shared set of lifestyle and eating
habits rather than amere assortment of specific micro- and macro-
nutrients (Trichopoulou 1997), we have performed some further
analyses to examine the effects of interventions describing them-
selves as the Mediterranean diet and those that do not. Where
this was possible, more comprehensive interventions targeting a
number of components simultaneously showed greater reductions
in total cholesterol than less comprehensive interventions. Future
updates of this review will explore this further whenmore evidence
accrues.
Agreements and disagreements with other
studies or reviews
We are not aware of any previous systematic review involving only
RCTs that has specifically examined the effectiveness of dietary ad-
vice to follow a Mediterranean-style diet or the provision of foods
relevant to the Mediterranean diet, as the only dietary interven-
tion compared with no or minimal intervention, for the primary
prevention of CVD in the general population of healthy adults
across all ages and among individuals at high risk of CVD.
For example, one systematic review and meta-analysis examined
the effectiveness of a Mediterranean-style diet compared with a
low-fat diet in RCTs among overweight/obese individuals with at
least one additional cardiovascular risk factor or with established
coronary artery disease (Nordmann 2011). Trials had to have a
minimum follow-up of six months, and to report ITT data on
cardiovascular risk factors (i.e. changes in body weight, blood pres-
sure and lipid levels). In this review, Mediterranean diets were de-
fined as diets with moderate-fat intake (where the main sources of
added fat were olive oil and nuts), rich in vegetables and low in
red meat (with poultry and fish replacing beef and lamb). Low-fat
diets were defined as diets aiming at an energy intake with 30% or
less of calories from fat, based on the American Heart Association
(AHA) dietary guidelines (Krauss 2000). Six trials were identified,
including one secondary prevention trial, with 2650 participants
randomised (50%women). Results of this meta-analysis suggested
favourable, though modest, effects of the Mediterranean diet, as
compared with a low-fat diet, on a wide range of cardiovascu-
lar risk factors and inflammatory markers, such as body weight,
systolic and diastolic blood pressure, fasting plasma glucose, total
cholesterol and high-sensitivity C-reactive protein. These results
are generally consistent with the favourable but relatively modest
effects on total cholesterol and blood pressure levels reported by
individual trials in our review. The main methodological differ-
ences between the two reviews were the inclusion or exclusion of
secondary prevention trials and the different definitions of the di-
etary intervention (whole dietary pattern vs. individual compo-
nents).
Other systematic reviews have pooled together the evidence from
both observational studies and RCTs on the effects of theMediter-
ranean dietary pattern on metabolic syndrome and individual
cardiovascular risk factors, supporting favourable effects of the
Mediterranean diet on cardio-metabolic risk factors (Buckland
2008; Kastorini 2011).
The large primary prevention trial PREDIMED, which did not
meet our strict inclusion criteria as the comparison group was not
minimal, has reported beneficial effects of the Mediterranean diet
on clinical endpoints (Estruch 2013). In this trial, 7447 partici-
pants were randomised to a dietary intervention that comprised
five components of our definition of aMediterranean-style dietary
pattern in contrast to two components for theWHI trial included
in our review that also reports clinical endpoints (WHI). After
4.8 years of follow-up, these authors showed a reduction of ma-
jor CVD events of 30% (HR 0.7, 95% CI 0.54 to 0.92) with
the Mediterranean dietary intervention and supplemented olive
oil compared with a low-fat control group (Estruch 2013). The
individuals recruited to this trial were all at high risk of CVD (type
2 diabetes or at least three CVD risk factors from smoking, hyper-
tension, hypercholesterolaemia, overweight or obesity, or family
history of CVD).
Likewise, systematic reviews and meta-analyses of observational
prospective studies have confirmed that a greater adherence to a
Mediterranean-style diet is associated with a significant improve-
ment in health status and a significant reduction in overall mortal-
ity, as well as in morbidity andmortality fromCVDand otherma-
jor chronic diseases (Sofi 2008; Sofi 2010). Specifically, in the latest
published meta-analysis of prospective cohort studies, a 2-point
increase (scale from 0 to 7-9 points) in adherence to a Mediter-
ranean dietary pattern was associated with an 8% reduction in all-
cause mortality and a 10% reduction in CVD incidence or mor-
tality (Sofi 2010).
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Implications for practice
Currently, there is limited trial evidence, especially on the effec-
tiveness of dietary advice to follow a Mediterranean-style dietary
pattern for the primary prevention of major cardiovascular clinical
outcomes. Only one trial reported clinical endpoints and this trial
was conducted in a selected group and the intervention was not
described as a Mediterranean diet satisfying only two components
of a possible seven in our classification. Therefore, more trial evi-
dence is needed to establish the role of the Mediterranean dietary
pattern as an effective lifestyle intervention to prevent cardiovas-
cular events in the general population and high-risk individuals
conclusively. Nevertheless, the available trial and observational ev-
idence is promising and generally supportive of favourable effects
of the Mediterranean-style diet on individual cardio-metabolic
risk factors and potentially cardiovascular morbidity and mortal-
ity. This evidence is also corroborated by the biological plausibil-
ity of several mechanisms to explain the beneficial effect of the
Mediterranean diet, as a whole, and of its individual components
on cardiovascular health (Serra-Majem 2006).
Indeed, some aspects and components of a Mediterranean-style
diet are already included in scientific and clinical guidelines for the
prevention of cardiovascular disease (CVD), such as the DASH
diet (AHA 2006; Appel 1997; Appel 2001; Appel 2006), and
eating guidance on consumption of at least five portions of fruit
and vegetables per day (Department of Health 2010).
Implications for research
There are currently very few randomised controlled trials thatmeet
our inclusion criteria to examine the effectiveness of dietary ad-
vice to follow a Mediterranean-style diet or the provision of foods
relevant to the Mediterranean diet for the primary prevention of
CVD. The limited trial evidence suggests some favourable effects
on cardiovascular risk factors but more trials are needed to confirm
this. In particular, there is a shortage of adequately powered clinical
trials on the effectiveness of the Mediterranean dietary pattern in
the primary prevention of major cardiovascular events both in the
general population and among those at high risk of CVD. High-
quality trials with long-term intervention and follow-up, measur-
ing costs and adverse effects are also necessary to determine the
sustainability of such dietary interventions across different popu-
lation subgroups and various cultural settings. With the accrual of
further evidence, the significant heterogeneity observed between
trials in terms of both the nature and duration of the intervention
and the range of participants recruited can be explored further and
its impact on outcomes examined.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Abedi 2010
Methods RCT of parallel group design.
Participants Postmenopausal women recruited from a health clinic in Iran.
Inclusion criteria: women had at least primary education, were postmenopausal (no
menstruation for at least 12 months) and CVD free (by self report)
76 women randomised, 38 in the intervention group (mean age (SD) 51.4 years (4.9)),
and 38 to the control group (mean age 51.6 years (5.7))
Interventions Dietary education to increase consumption of fruits and vegetables and whole grains,
to eat fish twice a week and limit saturated fat and salt. The intervention comprised 5
educational sessions (2 face-to-face and 3 lecture discussion classes with slide demonstra-
tions) in the first month, a further face-to-face session at month 3 and telephone calls
each month to remind women to remain on the diet. Information was also provided
about CVD and the menopause as well as diet. The intervention period was 6 months,
with follow-up at 6 months. The comparison group received no intervention
Outcomes Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides, SBP and DBP
Notes Differential loss to follow-up in the control group of greater than 20% so sensitivity
analyses were performed to examine the effect of excluding this study on the overall effect
estimates for lipid levels and blood pressure
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk Differential loss to follow-up of 7.9% in the interven-
tion group compared with 23.7% in the control group.
Participants in the intervention group did not attend
education sessions, reasons were not given for losses to
follow-up in the control group
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Abedi 2010 (Continued)
Selective reporting (reporting bias) Low risk Report all outcomes as stated.
Other bias Unclear risk Insufficient information to judge.
Castagnetta 2002
Methods RCT of parallel group design.
Participants Healthy postmenopausal female volunteers aged 44-71 years recruited by press campaign
from Palermo (Southern Italy)
Inclusion criteria: postmenopausal for at least 2 years, no history of bilateral ovariectomy,
no HRT within the previous year, no history of cancer, no adherence to a vegetarian or
macrobiotic diet, no treatment for diabetes, thyroid disease or chronic bowel disease
230 fulfilled these eligibility criteria and 115 women were enrolled in the study based on
serum testosterone levels equal to or greater than the median population level (0.14 µg/
mL). 58 women were randomised to the intervention group, 55 women to the control
group
Interventions MEDIET project - the intervention group were invited to a weekly cooking course and
to a social dinner with chefs addressing the principles of the traditional Mediterranean
diet. The proposed recipes were based on a traditional Sicilian diet including whole
cereals, legumes, seeds, fish, fruits, vegetables, olive oil and red wine. Women were asked
to avoid refined carbohydrates, salt and additional animal fat. The intervention ran for
6 months from January to June 2000, then from 3 months from October to December
2000. Women were instructed to consume the same foods on a daily basis at home.
The comparison group followed their usual diet. The follow-up period was at 6 and 12
months
Outcomes Plasma cholesterol.
Notes The primary publication (Castagnetta 2002) stated that the comparison group was ad-
vised to increase the consumption of fruits and vegetables as recommended by theWHO.
However, other reports of the study stated that women in the control group followed
their usual diets (Carruba 2006, secondary reference for this study)
No data were provided on cholesterol levels in the paper but simply a statement that they
had reduced. We have contacted the authors several times to request the data to include
in our analyses but, unfortunately, to date this has not been forthcoming
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Block randomisation stratified for baseline parameters.
Allocation concealment (selection bias) Unclear risk Not stated.
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Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No ITT analysis, < 20% loss to follow-up in both
groups but no reasons provided
Selective reporting (reporting bias) Unclear risk Insufficient information to judge.
Other bias Unclear risk Insufficient information to judge.
Djuric 2009
Methods RCT of parallel group design.
Participants Healthy non-obese women aged 25-65 years recruited from adverts in community
newsletters, health fairs, flyers and employee newsletters inMichigan, US.Women com-
pleted 7-day food diaries
Eligibility criteria: fat intake was at least 23% of calories with no more than 48% from
MUFA and fruit and vegetable intake was < 5.5 servings per day. This was to reflect
a typical American intake. Women had to have good general health, be current non-
smokers and be in the normal to overweight range (BMI 18-30)
Exclusion criteria: chronic diseases such as diabetes, autoimmune disease, hypertension,
being on medically prescribed diets, taking dietary supplements > 150% RDA, pregnant
or lactating and being treated with therapies or supplements that could obscure the
results. 69 women were randomised, mean age 44 years (range 25-59) and mean BMI
24 (19-30)
Interventions The intervention was a Greek Mediterranean exchange list diet with exchange goals de-
termined by dieticians at baseline and focused on increasing fruit and vegetable intake
and variety and increasing MUFA intake while maintaining the baseline energy intake
and total fat intake. The fruit and vegetable goal was 7-9 servings/day depending on
baseline calorie intake and maintaining baseline energy intake was achieved by substi-
tuting fruit and vegetables for other carbohydrates. Variety was achieved using exchange
lists. The fat intake goal was PUFA:SFA:MUFA ratio of 1:2:5. This was achieved by
reducing usual fat intakes by half using low-fat food and then adding in olive oil or other
high MUFA to the diet to keep energy and total fat intake at baseline levels. Participants
were given 3 L of extra-virgin olive oil at baseline and at 3 months. 7-day food records
were taken at baseline, 3 months and 6 months. Counselling by the dieticians occurred
weekly by telephone for the first 3 months and twice weekly thereafter. Face-to-face
counselling occurred at baseline and 3 months. The intervention period was 6 months.
Women were counselled on home eating patterns, restaurant eating, eating at work and
special occasions
The comparison group followed their usual diets. They did not receive counselling, but
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were given the National Cancer Institutes Action guide to healthy eating and written
materials on nutritional deficiencies if below 67% RDA. Follow-up was at 6 months
after the end of the intervention period
Outcomes Total cholesterol, LDL-cholesterol, HDL-cholesterol and triacylglycerol
Notes Differential loss to follow-up in the intervention group of > 20% so sensitivity analyses
were performed to examine the effect of excluding this study on the overall effect estimates
for lipid levels
Body weight increased by 0.24 kg in the control group and decreased by 1.21 kg in the
intervention group after the 6-month intervention period
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Method not stated. Subjects stratified by race and
menopausal status prior to randomisation using a block
design of 6
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
High risk Differential loss to follow-up of 23% in the interven-
tion group compared with 3% in the control group.
No reasons for loss to follow-up reported
Selective reporting (reporting bias) Low risk Report all outcomes as stated.
Other bias Unclear risk Insufficient information to judge.
ENCORE
Methods RCT of parallel group design.
Participants Participants were overweight or obese with untreated hypertension (SBP 130-159
mmHg, DBP 85-99 mmHg based on 4 screening visits) recruited from physician refer-
rals, community screenings, mass media advertising in North Carolina, US. 144 partic-
ipants randomised (46 to DASH alone, 49 to control), mean age was 52 years and 32.
6% were men
22’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
ENCORE (Continued)
Interventions The DASH diet:
• was low in saturated fat, cholesterol and total fat;
• focused on fruits, vegetables, and fat-free or low-fat dairy products;
• was rich in whole grains, fish, poultry, beans, seeds and nuts;
• contained fewer sweets, added sugars and sugary beverages, and red meats than
the typical American diet.
Participants in the intervention group received counselling on the DASH diet and pro-
vided feedback on their adherence in weekly group sessions. The goal of the sessions was
to assist participants in learning how to buy and prepare appropriate foods, enhance their
motivation to choose to eat these foods and to overcome any obstacles. A nutritionalist
made the recommendations and small group sessions were held weekly (30-45 minutes
each) at the research centre. Immediately after randomisation and before the counselling
sessions participants entered a 2-week controlled isocalorific feeding period to improve
compliance with the DASH diet. The comparison group were asked to maintain their
usual dietary and exercise habits. Follow-up was at 4months after the intervention period
Outcomes Total, HDL-cholesterol, LDL-cholesterol, triglycerides, SBP, DBP
Notes 2 intervention groups - DASH alone and DASH plus weight management. The review
looked at only at the DASH alone arm
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomised in groups of 2-5 participants using a com-
puter program
Allocation concealment (selection bias) Low risk Sealed envelopes used so allocation was concealed.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Participants were provided their treatment group as-
signments in sealed envelopes, which suggests theywere
unblinded. However, blinding of participants and per-
sonnel for behavioural interventions is difficult and of-
ten not possible so we have not judged this as at high
risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Staff members performing the assessments were un-
aware of group assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 participant lost to follow-up and ITT analysis
used.
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Unclear risk Insufficient information to judge.
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Methods RCT of parallel group design.
Participants Men and women were recruited from June 2001 to January 2004 among those attending
the outpatient department of theDivision ofMetabolicDiseases at the SecondUniversity
of Naples, Naples, Italy. 180 adults (99 men and 81 women), mean age 44.3 years
(intervention diet) and 43.5 years (control diet) with metabolic syndrome were enrolled
in the study
Inclusion criteria: ≥ 3 of the following: (1) abdominal adiposity (defined as waist cir-
cumference 102 cm (men) or 88 cm (women)); (2) low levels of serumHDL-cholesterol
(40 mg/dL (men) or 50 mg/dL (women)); (3) hypertriglyceridaemia (triglycerides level
of ≥ 150 mg/dL); (4) elevated blood pressure (≥ 130/85 mmHg); and (5) impaired
glucose homeostasis (fasting plasma glucose concentration ≥ 110 mg/dL)
Exclusion criteria: CVD, psychiatric problems, a history of alcohol abuse (alcohol con-
sumption 500 g/week in the last year), if they smoked, or if they took any medication
Interventions Intervention diet: 90 participants were given detailed advice about the usefulness of a
Mediterranean-style diet. Through a series of monthly small-group sessions, participants
received education in reducing dietary calories (if needed), personal goal-setting and
self monitoring using food diaries. Behavioural and psychological counselling was also
offered.Dietary advice was tailored to each participant on the basis of 3-day food records.
The recommended composition of the dietary regimen was carbohydrates, 50-60%;
proteins, 15-20%; total fat, < 30%; saturated fat, < 10%; and cholesterol consumption,
< 300 mg/day. Participants were advised to consume at least 250-300 g of fruits, 125-
150 g of vegetables, 25-50 g of walnuts, 400 g of whole grains (legumes, rice, maize
and wheat) daily and to increase their consumption of olive oil. Participants were in the
programme for 24 months and had monthly sessions with the nutritionist for the first
year and twice monthly sessions for the second year. Compliance with the programme
was assessed by attendance at the meetings and completion of diet diaries
Control diet: 90 participants were given general oral and written information about
healthy food choices at baseline and at subsequent visits. The general recommendation
for macro-nutrient composition of the diet was similar to that for the intervention
group (carbohydrates, 50-60%; proteins, 15-20% and total fat, 30%). Participants had
bimonthly sessions with study personnel
Participants in both groups also received guidance on increasing their level of physical
activity, mainly by walking for a minimum of 30 minutes/day but also by swimming or
playing aerobic ball games
Trial was conducted from June 2001 to January 2004. Follow-up period was 2 years
Outcomes Total cholesterol, HDL-cholesterol, triglycerides, SBP, SBP.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random number sequence.
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Allocation concealment (selection bias) Low risk Stored in sealed study folders and held in a central,
secured location until informed consent obtained
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Staff members involved in the intervention had to be
aware of the group assignment; thus, the study was only
partly blinded. Blinding of participants and personnel
for behavioural interventions is difficult and often not
possible, so we have not judged this as at high risk of
bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Laboratory staff did not know to which group the par-
ticipants were assigned
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis.
Selective reporting (reporting bias) Low risk All expected outcomes reported.
Other bias Unclear risk Insufficient information to judge.
Jula 2002
Methods RCT cross-over design (analysed as a parallel group, 12-week intervention, 12-week
follow-up)
Participants Hypercholesterolaemic men, 35-64 years of age were screened from the clients of the
occupational health service of 5 industrial plants and government offices in Turku in
southwestern Finland. 120 men were enrolled
Inclusion criteria: a fasting serum cholesterol concentration 232-309 mg/dL (6.0-8.0
mmol/L) and fasting serum triglyceride concentration no higher than 266 mg/dL (3.0
mmol/L)
Exclusion criteria: BMI > 32 kg/m2; coronary artery disease; cerebrovascular disease;
claudication and pharmacologically treated hypertension, hyperlipidaemia, or diabetes
Interventions Men included in the study entered first a 4- to 6-week open placebo run-in period, at
the end of which they were randomly allocated to the intervention (60 men, mean age
48.0 years) or control group (60 men, mean age 48.4 years)
The intervention (a weight stable, modified, Mediterranean-type diet) consisted of no
more than 10% energy from SFAa and transunsaturated fatty acids; cholesterol intake
no more than 250 mg/day; omega-3 fatty acid intake of plant origin (linolenic acid)
and marine origin of at least 4 g/day and the ratio of omega-6/omega-3 PUFAs < 4;
and increased intakes of fruits, vegetables and soluble fibre. Men were advised to use
leaner meat products, low-fat cheese, skimmed milk, fat-free sour milk and low-fat
yogurt. Fish was recommended as a main meal once or twice a week. Rapeseedmargarine
was recommended as a replacement for butter, a mixture of butter and vegetable oils,
and sunflower margarine. Rapeseed margarine and oil, oat bran (20 g/day), and frozen
berries (blueberry, lingonberry or blackcurrant at 50 g/day) were supplied free to study
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subjects. The diet was supervised by a nutritionist in 1 individual session and in 2 group
counselling sessions at the beginning of the treatment and in 5 subsequent monthly
group brush-up sessions during the dietary treatment. The control group participants
(habitual diet group) were advised to continue eating their usual diet during the study
period
The trial was conducted between August 1997 and June 1998.
Outcomes Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides
Notes Data were only used for the first 12 weeks of the trial (before the second randomisation
and subsequent cross-over). Follow-up data (mean and SD) for each of the outcomes
was missing. Authors were contacted 3 times for follow-up data for all outcomes but
with no success
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Dietary treatment was performed single-
blind. Blinding of participants and person-
nel for behavioural interventions is diffi-
cult and often not possible so we have not
judged this as at high risk of bias
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All measurements and analyses were done
blinded to the treatment allocation of the
subject
Incomplete outcome data (attrition bias)
All outcomes
High risk No reason given for attrition.
Selective reporting (reporting bias) Unclear risk Blood pressure not reported.
Other bias Unclear risk Insufficient information to judge.
Konstantinidou 2010
Methods RCT of parallel group design.
Participants From October 2007 to October 2008, 90 eligible community-dwelling adults (26 men
and 64 women, aged 20-50 years) were recruited from primary care centres. They were
considered healthy on the basis of a physical examination and routine biochemical and
haematological laboratory determinations
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Exclusion criteria: intake of antioxidant supplements; intake of acetosalicylic acid or any
other drug with established antioxidative properties; high levels of physical activity (3000
kcal/week in leisure-time physical activity); obesity (BMI 30 kg/m2); hypercholestero-
laemia (total cholesterol 8.0 mM or dyslipidaemia therapy); diabetes (glucose 126 mg/
dL or diabetes treatment); hypertension (SBP ≥ 140 mmHg) or (DBP ≥ 90 mmHg)
, or both or antihypertensive treatment; multiple allergies; coeliac or other intestinal
diseases; any condition that could limit the mobility of the subject, making study visits
impossible; life-threatening illnesses or other diseases or conditions that could worsen
adherence to the measurements or treatments; vegetarianism or a need for other special
diets; and alcoholism or other drug addiction
Interventions Participants were assigned to 1 of 2 interventions or a control group as follows:
1. Traditional Mediterranean diet with virgin olive oil (30 participants);
2. Traditional Mediterranean diet with washed virgin olive oil (30 participants)
The dietician gave personalised advice during a 30-minute session to each participant
following the traditional Mediterranean diets, with recommendations on the desired
frequency of intake of specific foods. Participants were instructed to use olive oil for
cooking and dressing; increase consumption of fruit, vegetables and fish; consume white
meat instead of red or processed meat; prepare homemade sauce with tomato, garlic,
onion, aromatic herbs and olive oil to dress vegetables, pasta, rice, and other dishes; and,
for alcohol drinkers, moderate consumption of red wine
3. Control group (30 subjects): participants were advised by a dietician to maintain their
habitual lifestyle
Intervention period and follow-up was 3 months.
Outcomes Total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, SBP, DBP
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer generated random number sequence.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 1 participant dropped out of the trial.
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Selective reporting (reporting bias) Unclear risk Not stated.
Other bias Unclear risk Not stated.
Lanza 2001
Methods RCT of parallel group design.
Participants The Polyp Prevention Trial - a multicentre trial (8 US clinical centres) to examine the
effect of diet on recurrence of adenomatous polyps in the large bowel. Participants were
at high risk with ≥ 1 colorectal adenomas removed within 6 months before recruitment.
Referrals were from endoscopists and recruitment took place between 1991 and 1994.
2079 participants were randomised, 64.5% men, mean age 61 years
Interventions Intensive counselling to follow a low-fat (< 20% calories), high-fibre (18 g/1000 cal) diet
and to increase fruit and vegetable consumption to 3.5 servings/1000 cal. Nutritional
education and behavioural modification techniques used by a registered dietician. In the
first year, counselling sessions were weekly for the first 6 weeks, biweekly for the next
6 weeks and monthly thereafter. In year 2, counselling sessions were in groups every
2 months and participants were also contacted by telephone at least once a month. In
years 3 and 4, counselling sessions were held quarterly in groups. More than 50 hours
of counselling sessions over 4 years. Comparison group were given a standard brochure
on healthy eating. Follow-up at 4 years
Outcomes Plasma cholesterol in mmoles/litre
Notes Plasma cholesterol only measured in a subgroup of participants, n = 370 and n = 374
for the intervention and control groups, respectively
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis used and loses to follow-up reported.
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Selective reporting (reporting bias) Low risk All outcomes stated are reported.
Other bias Unclear risk Insufficient information to judge.
Lindman 2004
Methods RCT of parallel group design (2 x 2 factorial design).
Participants 219 older men with long-standing hypercholesterolaemia were recruited from the Diet
and Omega-3 Intervention trial on atherosclerosis (DOIT) study, Norway. Mean age
69.7 years for both genotypes
Interventions Men were randomised into 3 intervention groups or the control group as follows:
• usual care and placebo capsules (control group) (n = 51);
• dietary advice (’Mediterranean-type’ diet) and placebo capsules (n = 47);
• usual care and VLC n-3 capsules (n = 51);
• dietary advice (’Mediterranean-type’ diet) and VLC n-3 capsules (n = 52).
Diet counselling was given individually by a clinical nutritionist based on a food fre-
quency questionnaire. The food frequency questionnaire was also answered by the par-
ticipants at the end of the main study (36 months). Energy content and nutrient compo-
sition was of the diet were calculated from the questionnaires at baseline and 36 months.
Dietary advice was given during 30-45 minutes at time of randomisation, and for 30
minutes after 3 months. Participants were supported with a margarine rich in PUFA and
vegetable oils free of cost. Advice was given to increase intake of vegetables, fruit and fish,
and decrease consumption of meat and target energy percents at 27-30% fat, 15-18%
protein and 50-55% carbohydrate. To fulfil these goals participants were recommended
to use rapeseed or olive oil for cooking; use leafy vegetables daily; include fruits, berries
and nuts in the diet; eat fish 3 times per week; use wholemeal bread, skimmed milk and
reduced-fat cheese. 2 capsules were taken twice daily corresponding to 2.4 g VLC n-3
capsules or 2.4 g corn oil (placebo capsules)
Follow-up period was 6 months.
Outcomes Triglycerides.
Notes Only data from the usual care and placebo capsules (control group) (n = 51) and dietary
advice (’Mediterranean type’ diet) and placebo capsules (n = 47). (The focus of the study
was to investigate the effect of long-term diet and VLC n-3 fatty acids intervention
on plasma coagulation factor VII (FVII), choline-containing phospholipids and triglyc-
erides, especially relating to the R353Q polymorphism of the FVII gene)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Not stated.
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Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Not stated.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Insufficient reporting of attrition/exclu-
sions.
Selective reporting (reporting bias) Unclear risk Insufficient information to judge.
Other bias Unclear risk Insufficient information to judge.
Wardle 2000
Methods RCT of parallel group design.
Participants Participants were adults withmild tomoderate hypercholesterolaemiawith serum choles-
terol levels above 5.2 mmol/L, not current or previous (within 3 months) users of lipid-
loweringmedication and with no serious illness. Participants were recruited from dietetic
clinics, hospital physicians and general practitioners in London and the South East, UK.
117 participants were randomised, mean age 53.5 years, 43.5% men
Interventions The intervention (Mediterranean diet) was delivered in 8 sessions during the 12-week
intervention period using a combination of individual and group sessions with a dietician
and psychologist. Dietary advice was to increase intake of fruit and vegetables, and oily
fish and to reduce fat to 30% of energy with substitution of predominantly monosatu-
rated fat for saturated fat. All participants received individualised advice to implement
dietary changes based on their lifestyle and food preferences and group support in main-
taining changes. Intervention participants were also given free spreading fats and oils
high in monosaturated fats. The comparison group was a wait-list control. Participants
were told it was necessary to wait for treatment but that they would be seen at 6-week
intervals. They were not given any specific dietary advice but were not discouraged from
making changes and some participants did so. 12 weeks’ follow-up
Outcomes Total cholesterol, LDL-cholesterol, HDL-cholesterol, triglycerides
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Random sequence generation (selection
bias)
Unclear risk Not stated.
Allocation concealment (selection bias) Low risk Opaque sealed envelopes.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk No details provided but the control group was a wait-
list control
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Outcome assessment done by a member of the research
team who was blinded (in most cases)
Incomplete outcome data (attrition bias)
All outcomes
Low risk No ITT but details of attrition provided and reasons.
Selective reporting (reporting bias) Low risk All of the outcomes stated were reported.
Other bias Unclear risk Insufficient information to judge.
WHI
Methods RCT of parallel group design.
Participants 48,835 postmenopausal women aged 50-79 years were recruited and enrolled between
1993 and 1998 at 40 clinical centres across the US
Eligibility criteria: being postmenopausal and consuming at baseline a diet with fat intake
of 32% or more of total calories, as assessed by a food frequency questionnaire
Exclusion criteria: history of breast cancer or colorectal cancer, any cancer within the
previous 10 years except non-melanoma skin cancer, medical conditions with a predicted
survival of less than 3 years, adherence or retention concerns, current dietary intake of
less than 32% of energy from fat, and type 1 diabetes mellitus
Interventions Women were randomly assigned to a usual-diet comparison group (n = 29,294, 60.0%)
or an intervention group with a 20% low-fat dietary pattern with increased vegetables,
fruits and grains (n = 19,541, 40.0%)
The intervention was designed to promote dietary change with the goals of reducing
intake of total fat to 20% of energy intake (in kilocalories) by increasing intake of
vegetables and fruits to at least 5 servings daily and of grains to at least 6 servings daily.
The intervention did not include total energy reduction or weight loss goals. Although
not a separate focus of the intervention, it was presumed that by reducing total fat
intake to 20% kcal, intake of saturated fat would also be reduced (7% energy intake)
. The intensive behavioural modification programme involved 18 group sessions in the
first year and quarterly maintenance sessions thereafter, led by specially trained and
certified nutritionists. Participants self monitored total fat-gram intake and also servings
of vegetables, fruits and grains
Women in the comparison group received a copy of the Dietary Guidelines for Amer-
icans as well as other health-related materials, but had no contact with the nutrition
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interventionists
Mean follow-up time for the WHI DMT was 8.1 years.
Outcomes CVDmortality, myocardial infarction and stroke (at 8.1 years); total cholesterol, HDL-
cholesterol and LDL-cholesterol (at year 3); triglycerides (at year 3); SBP and DBP (at
years 1 and 3); type 2 diabetes (at 8.1 years)
Notes Blood measures (total, HDL-cholesterol, LDL-cholesterol and triglycerides) were per-
formed on a 5.8% subsample at year 3
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used a randomised permuted block algorithm.
Allocation concealment (selection bias) Unclear risk Not stated.
Blinding of participants and personnel
(performance bias)
All outcomes
Unclear risk Not stated.
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Carried out by physician adjudicators not involved in
trial.
Incomplete outcome data (attrition bias)
All outcomes
Low risk ITT analysis.
Selective reporting (reporting bias) Low risk All outcomes reported.
Other bias Unclear risk Insufficient information to judge.
BMI: body mass index; CVD: cardiovascular disease; DASH: ; DBP: diastolic blood pressure; HDL: high-density lipoprotein; HRT:
hormone replacement therapy; ITT: intention to treat; LDL: low-density lipoprotein; MUFA: monounsaturated fatty acid; PUFA:
polyunsaturated fatty acid; RCT: randomised controlled trial; RDA: recommended daily allowance; SBP: systolic blood pressure;
SD: standard deviation; SFA: saturated fatty acid; VLC: very-long-chain; WHO: World Health Organization.
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Azadbakht 2005 Not an RCT - control group were a separate population.
Barcelo 2009 PREDIMED study. Low-fat diet arm had face-to-face nutritional advice as well as leaflets, therefore, not a
minimal control
Bullo 2009 Substudy of PREDIMED. Control group received face-to-face nutritional advice, therefore, not a minimal
control, and there were no relevant outcomes
Mezzano 2003 Not all subjects were randomised.
Papadaki 2008 Not an RCT.
Vincent-Baudry 2005 Medi-RIVAGE study. Control group was given dietary advice to eat fruit and vegetables, therefore, not a
minimal control
RCT: randomised controlled trial.
Characteristics of studies awaiting assessment [ordered by study ID]
Inguaggiato 2011
Methods RCT of parallel group design
Participants 219 participants with metabolic syndrome (NCEP-ATPIII criteria)
Interventions 4 intervention groups: to follow a Mediterranean diet, a low GI Mediterranean diet, low GI diet and a generic diet
(comparison group). Follow-up after the 12-week intervention period
Outcomes Lipid levels, blood pressure
Notes Conference abstract. Contacted authors for further details of the trial and outcome data. Authors are currently trying
to publish a paper and are unwilling at present to share their data with us
GI: glycaemic index; NCEP-ATPIII: National Cholesterol Education Program- Adult Treatment Panel III; RCT: randomised controlled
trial.
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Sanders 2012
Trial name or title Cardiovascular risk REduction Study: Supported by an Integrated Dietary Approach
Methods Randomised parallel design single-centre controlled trial
Participants Inclusion criteria:
1. Healthy men and women, aged 40-70 years
Exclusion criteria:
1. a reported history of angina, myocardial infarction, peripheral vascular disease, congenital heart disease
or stroke;
2. Asymptomatic atrial fibrillation;
3. type 1 or type 2 diabetes mellitus (fasting plasma glucose > 7 mmol/L);
4. seated blood pressure > 160/105 mmHg;
5. current use of medication for lowering blood cholesterol (statins) or blood pressure;
6. body mass index < 18.5 and > 35 kg/m2;
7. an overall risk of cardiovascular disease over the next 10 years of > 20% assessed according to current
NICE guidelines in combination with untreated hypertension or raised cholesterol;
8. clinical history of cancer (excluding basal cell carcinoma) in the past 5 years;
9. chronic renal, liver or inflammatory bowel disease;
10. current cigarette smoker (confirmed by urinary cotinine analysis);
11. history of substance abuse or alcoholism (previous weekly alcohol intake > 60 units/men or 50 units/
women);
12. current self reported weekly alcohol intake not exceeding 21 units for women and 28 units for men;
13. currently pregnant, planning pregnancy or having had a baby in the last 12 months;
14. unwilling to follow the protocol or give informed consent, or both;
15. unwilling to refrain from use of dietary supplements;
16. unwilling to restrict consumption of oily fish;
17. weight change of > 3 kg in preceding 2 months
Interventions This is a controlled dietary intervention trial comparing a cardioprotective diet (decreased salt and saturated
fatty acid intake, and increased whole grain cereals, fruit and vegetables and oily fish intake) with a control
diet (average UK diet) for 3 months
Outcomes Primary outcome measures:
1. a change in systolic blood pressure measured by ambulatory blood pressure;
2. a change in endothelial function measured by flow-mediated dilation;
3. a change in total/high-density lipoprotein (HDL) cholesterol ratio measured at baseline and 3 months.
Secondary outcome measures:
1. a change in arterial stiffness (pulse wave velocity and digital volume pulse), measured at baseline and 3
months;
2. a change in insulin sensitivity (revised quantitative insulin sensitivity test (RQUICKI) and serum
adiponectin), measured at baseline and 3 months;
3. a change in C-reactive protein concentrations, measured at baseline and 3 months.
Starting date 16 July 2010
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Sanders 2012 (Continued)
Contact information Prof Thomas Sanders
Nutritional Science Division
4th Floor, Franklin-Wilkins Building
150 Stamford Street
London
SE1 9NH
UK
+44 (0)20 7848 4273
+44 (0)20 7848 4171
tom.sanders@kcl.ac.uk
Notes Ongoing trial (ISRCTN92382106) that has been classified as ’completed’ on www.controlled-trials.com
Trial website: www.medscinet.net/CRESSIDA/
Study duration: July 2010 to December 2012
NICE: national Institute for Health and Clinical Excellence.
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D A T A A N D A N A L Y S E S
Comparison 1. Mediterranean dietary intervention versus no intervention or minimal intervention (secondary
outcomes - CVD risk factors)
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Total cholesterol (mmol/L),
change from baseline
8 4151 Mean Difference (IV, Random, 95% CI) -0.16 [-0.26, -0.06]
2 Total cholesterol (mmol/L),
change from baseline, subgroup
analysis
8 3815 Mean Difference (IV, Fixed, 95% CI) -0.20 [-0.23, -0.17]
2.1 Interventions described
as Mediterranean diet (or
comprise both increased
fruit and vegetables and
monounsaturated fatty acids)
4 436 Mean Difference (IV, Fixed, 95% CI) -0.23 [-0.27, -0.20]
2.2 Interventions with 2
components but not described
as Mediterranean diet or
comprising both increased
fruit and vegetables and
monounsaturated fatty acids
4 3379 Mean Difference (IV, Fixed, 95% CI) -0.06 [-0.13, 0.01]
3 LDL-cholesterol (mmol/L),
change from baseline
6 3227 Mean Difference (IV, Fixed, 95% CI) -0.07 [-0.13, -0.01]
4 LDL-cholesterol (mmol/L),
change from baseline, subgroup
analysis
6 3227 Mean Difference (IV, Random, 95% CI) -0.07 [-0.17, 0.03]
4.1 Interventions described
as Mediterranean diet (or
comprise both increased
fruit and vegetables and
monounsaturated fatty acids)
3 252 Mean Difference (IV, Random, 95% CI) -0.16 [-0.39, 0.07]
4.2 Interventions with 2
components but not described
as the Mediterranean diet or
comprising both increased
F&V and MUFAs
3 2975 Mean Difference (IV, Random, 95% CI) -0.06 [-0.12, 0.00]
5 HDL-cholesterol (mmol/L),
change from baseline
7 Mean Difference (IV, Fixed, 95% CI) Totals not selected
6 Triglycerides (mmol/L), change
from baseline
6 Mean Difference (IV, Fixed, 95% CI) Totals not selected
7 Systolic blood pressure (mmHg),
change from baseline
5 Mean Difference (IV, Fixed, 95% CI) Totals not selected
8 Diastolic blood pressure
(mmHg), change from baseline
5 Mean Difference (IV, Fixed, 95% CI) Totals not selected
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Analysis 1.1. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 1 Total cholesterol (mmol/L), change from
baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 1 Total cholesterol (mmol/L), change from baseline
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Abedi 2010 35 0.31 (0.67) 29 0.31 (1) 4.7 % 0.0 [ -0.43, 0.43 ]
Djuric 2009 27 -0.026 (0.97) 33 -0.1 (0.86) 4.0 % 0.08 [ -0.39, 0.55 ]
ENCORE 46 0 (0.88) 49 -0.03 (0.88) 6.4 % 0.03 [ -0.32, 0.38 ]
Esposito 2004 90 -0.284 (0.155) 90 -0.05 (0.052) 25.7 % -0.23 [ -0.27, -0.20 ]
Konstantinidou 2010 60 -0.125 (0.6) 29 0 (0.6) 9.5 % -0.12 [ -0.39, 0.14 ]
Lanza 2001 370 -0.14 (0.96) 374 0.07 (0.88) 18.3 % -0.21 [ -0.34, -0.08 ]
Wardle 2000 53 -0.7 (0.91) 50 -0.2 (0.68) 7.8 % -0.50 [ -0.81, -0.19 ]
WHI 1408 -0.26 (0.93) 1408 -0.2 (0.97) 23.5 % -0.06 [ -0.13, 0.01 ]
Total (95% CI) 2089 2062 100.0 % -0.16 [ -0.26, -0.06 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 26.49, df = 7 (P = 0.00041); I2 =74%
Test for overall effect: Z = 3.01 (P = 0.0026)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.2. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 2 Total cholesterol (mmol/L), change from
baseline, subgroup analysis.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 2 Total cholesterol (mmol/L), change from baseline, subgroup analysis
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)
Djuric 2009 35 -0.026 (0.97) 29 0.31 (1) 0.4 % -0.34 [ -0.82, 0.15 ]
Esposito 2004 90 -0.284 (0.155) 90 -0.05 (0.052) 77.6 % -0.23 [ -0.27, -0.20 ]
Konstantinidou 2010 60 -0.125 (0.6) 29 0 (0.6) 1.3 % -0.12 [ -0.39, 0.14 ]
Wardle 2000 53 -0.7 (0.91) 50 -0.2 (0.68) 0.9 % -0.50 [ -0.81, -0.19 ]
Subtotal (95% CI) 238 198 80.1 % -0.23 [ -0.27, -0.20 ]
Heterogeneity: Chi2 = 3.71, df = 3 (P = 0.29); I2 =19%
Test for overall effect: Z = 13.79 (P < 0.00001)
2 Interventions with 2 components but not described as Mediterranean diet or comprising both increased fruit and vegetables and monounsaturated fatty acids
Abedi 2010 35 0.31 (0.67) 29 0.31 (1) 0.5 % 0.0 [ -0.43, 0.43 ]
ENCORE 46 0 (0.88) 49 -0.03 (0.88) 0.7 % 0.03 [ -0.32, 0.38 ]
Lanza 2001 30 -0.14 (0.96) 374 0.07 (0.88) 0.7 % -0.21 [ -0.56, 0.14 ]
WHI 1408 -0.26 (0.93) 1408 -0.2 (0.97) 18.0 % -0.06 [ -0.13, 0.01 ]
Subtotal (95% CI) 1519 1860 19.9 % -0.06 [ -0.13, 0.01 ]
Heterogeneity: Chi2 = 1.01, df = 3 (P = 0.80); I2 =0.0%
Test for overall effect: Z = 1.78 (P = 0.075)
Total (95% CI) 1757 2058 100.0 % -0.20 [ -0.23, -0.17 ]
Heterogeneity: Chi2 = 25.45, df = 7 (P = 0.00063); I2 =72%
Test for overall effect: Z = 13.14 (P < 0.00001)
Test for subgroup differences: Chi2 = 20.73, df = 1 (P = 0.00), I2 =95%
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.3. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 3 LDL-cholesterol (mmol/L), change from
baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 3 LDL-cholesterol (mmol/L), change from baseline
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abedi 2010 35 -0.155 (0.7) 29 -0.33 (0.88) 2.2 % 0.18 [ -0.22, 0.57 ]
Djuric 2009 27 -0.052 (0.85) 33 -0.13 (0.69) 2.2 % 0.08 [ -0.32, 0.48 ]
ENCORE 46 0 (0.78) 49 -0.03 (0.8) 3.4 % 0.03 [ -0.29, 0.35 ]
Konstantinidou 2010 60 -0.07 (0.45) 29 0.05 (0.46) 8.5 % -0.12 [ -0.32, 0.08 ]
Wardle 2000 53 -0.6 (0.91) 50 -0.2 (0.81) 3.2 % -0.40 [ -0.73, -0.07 ]
WHI 1408 -0.26 (0.89) 1408 -0.19 (0.89) 80.5 % -0.07 [ -0.14, 0.00 ]
Total (95% CI) 1629 1598 100.0 % -0.07 [ -0.13, -0.01 ]
Heterogeneity: Chi2 = 6.40, df = 5 (P = 0.27); I2 =22%
Test for overall effect: Z = 2.41 (P = 0.016)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.4. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 4 LDL-cholesterol (mmol/L), change from
baseline, subgroup analysis.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 4 LDL-cholesterol (mmol/L), change from baseline, subgroup analysis
Study or subgroup Experimental Control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 Interventions described as Mediterranean diet (or comprise both increased fruit and vegetables and monounsaturated fatty acids)
Djuric 2009 27 -0.052 (0.85) 33 -0.13 (0.69) 5.8 % 0.08 [ -0.32, 0.48 ]
Konstantinidou 2010 60 -0.07 (0.45) 29 0.05 (0.46) 18.1 % -0.12 [ -0.32, 0.08 ]
Wardle 2000 53 -0.6 (0.91) 50 -0.2 (0.81) 8.0 % -0.40 [ -0.73, -0.07 ]
Subtotal (95% CI) 140 112 31.8 % -0.16 [ -0.39, 0.07 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 3.52, df = 2 (P = 0.17); I2 =43%
Test for overall effect: Z = 1.33 (P = 0.18)
2 Interventions with 2 components but not described as the Mediterranean diet or comprising both increased F%V and MUFAs
Abedi 2010 35 -0.155 (0.7) 29 -0.33 (0.88) 5.8 % 0.18 [ -0.22, 0.57 ]
ENCORE 46 0 (0.78) 49 -0.03 (0.8) 8.7 % 0.03 [ -0.29, 0.35 ]
WHI 1408 -0.26 (0.89) 1408 -0.19 (0.89) 53.6 % -0.07 [ -0.14, 0.00 ]
Subtotal (95% CI) 1489 1486 68.2 % -0.06 [ -0.12, 0.00 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.75, df = 2 (P = 0.42); I2 =0.0%
Test for overall effect: Z = 1.84 (P = 0.066)
Total (95% CI) 1629 1598 100.0 % -0.07 [ -0.17, 0.03 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 6.40, df = 5 (P = 0.27); I2 =22%
Test for overall effect: Z = 1.45 (P = 0.15)
Test for subgroup differences: Chi2 = 0.63, df = 1 (P = 0.43), I2 =0.0%
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.5. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 5 HDL-cholesterol (mmol/L), change from
baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 5 HDL-cholesterol (mmol/L), change from baseline
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abedi 2010 35 0.01 (0.18) 29 0 (0.18) 0.01 [ -0.08, 0.10 ]
Djuric 2009 27 0.026 (0.31) 33 0 (0.37) 0.03 [ -0.15, 0.20 ]
ENCORE 46 -0.07 (0.3) 49 -0.03 (0.327) -0.04 [ -0.17, 0.09 ]
Esposito 2004 90 0.103 (0.052) 90 0.03 (0.026) 0.08 [ 0.06, 0.09 ]
Konstantinidou 2010 60 -0.05 (0.18) 29 -0.05 (0.18) 0.00 [ -0.08, 0.08 ]
Wardle 2000 53 -0.1 (0.34) 50 -0.04 (0.28) -0.06 [ -0.18, 0.06 ]
WHI 1408 -0.01 (0.41) 1408 -0.01 (0.4) -0.01 [ -0.03, 0.02 ]
-0.5 -0.25 0 0.25 0.5
Favours control Favours experimental
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Analysis 1.6. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 6 Triglycerides (mmol/L), change from
baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 6 Triglycerides (mmol/L), change from baseline
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abedi 2010 35 -0.21 (0.78) 29 -0.16 (0.97) -0.05 [ -0.49, 0.39 ]
Djuric 2009 27 0.034 (0.47) 33 0.03 (0.41) 0.0 [ -0.23, 0.23 ]
ENCORE 46 0.08 (0.56) 49 0.09 (0.57) -0.01 [ -0.24, 0.22 ]
Esposito 2004 90 -0.203 (0.09) 90 0.01 (0.034) -0.21 [ -0.23, -0.19 ]
Wardle 2000 53 0.3 (0.56) 50 -0.06 (0.53) 0.36 [ 0.15, 0.57 ]
WHI 1408 0.04 (0.75) 1408 0.04 (0.73) 0.0 [ -0.05, 0.05 ]
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.7. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 7 Systolic blood pressure (mmHg), change
from baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 7 Systolic blood pressure (mmHg), change from baseline
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abedi 2010 35 2.5 (16) 29 3.6 (10) -1.10 [ -7.53, 5.33 ]
ENCORE 46 -11.2 (10.7) 49 -3.4 (10.7) -7.80 [ -12.11, -3.49 ]
Esposito 2004 90 -4 (2) 90 -1 (1) -3.00 [ -3.46, -2.54 ]
Konstantinidou 2010 60 -1.03 (10.79) 29 1.4 (11) -2.43 [ -7.28, 2.42 ]
WHI 17126 -2.7 (17.15) 25173 -2 (16.9) -0.70 [ -1.03, -0.37 ]
-10 -5 0 5 10
Favours experimental Favours control
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Analysis 1.8. Comparison 1 Mediterranean dietary intervention versus no intervention or minimal
intervention (secondary outcomes - CVD risk factors), Outcome 8 Diastolic blood pressure (mmHg), change
from baseline.
Review: ’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease
Comparison: 1 Mediterranean dietary intervention versus no intervention or minimal intervention (secondary outcomes - CVD risk factors)
Outcome: 8 Diastolic blood pressure (mmHg), change from baseline
Study or subgroup Experimental Control
Mean
Difference
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Abedi 2010 35 -1 (11.2) 29 0.7 (10.5) -1.70 [ -7.03, 3.63 ]
ENCORE 46 -7.5 (6.05) 49 -3.8 (5.89) -3.70 [ -6.10, -1.30 ]
Esposito 2004 90 -3 (1) 90 -1 (1) -2.00 [ -2.29, -1.71 ]
Konstantinidou 2010 60 0.17 (7.8) 29 1.67 (8) -1.50 [ -5.02, 2.02 ]
WHI 17125 -2 (9.15) 25169 -1.3 (9.05) -0.70 [ -0.88, -0.52 ]
-10 -5 0 5 10
Favours experimental Favours control
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Central Register of Controlled Trials (CENTRAL), DARE, HTA, NHS EED (The Cochrane Library) to September
2012
#1 MeSH descriptor: [Fruit] explode all trees
#2 fruit*
#3 MeSH descriptor: [Vegetables] explode all trees
#4 MeSH descriptor: [Vegetable Proteins] this term only
#5 vegetable*
#6 MeSH descriptor: [Fabaceae] explode all trees
#7 fabaceae
#8 bean*
#9 legume*
#10 MeSH descriptor: [Lycopersicon esculentum] this term only
#11 lycopersicon next esculent*
#12 tomato*
#13 solanum next lycopersicum
#14 MeSH descriptor: [Nuts] this term only
#15 nut or nuts
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#16 MeSH descriptor: [Bread] this term only
#17 bread*
#18 MeSH descriptor: [Cereals] explode all trees
#19 cereal*
#20 grain*
#21 MeSH descriptor: [Solanum tuberosum] this term only
#22 solanum next tuberosum
#23 potato*
#24 MeSH descriptor: [Seeds] this term only
#25 seed or seeds
#26 olive next oil
#27 MeSH descriptor: [Fatty Acids, Monounsaturated] this term only
#28 monounsaturated next fat*
#29 mono-unsaturated next fat*
#30 MeSH descriptor: [Seafood] explode all trees
#31 MeSH descriptor: [Fish Oils] explode all trees
#32 fish
#33 seafood*
#34 shellfish
#35 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10
#36 #11 or #12 or #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20
#37 #21 or #22 or #23 or #24 or #25 or #26 or #27 or #28 or #29 or #30
#38 #31 or #32 or #33 or #34
#39 #35 or #36 or #37 or #38
#40 (high or more or increase* or elevat* or much or rais*) near/6 (intake or consumption or consume or eat* or amount*)
#41 #39 and #40
#42 MeSH descriptor: [Dairy Products] explode all trees
#43 MeSH descriptor: [Milk Proteins] explode all trees
#44 milk*
#45 marg?rine*
#46 butter*
#47 dairy
#48 cheese*
#49 red next meat*
#50 processed next meat*
#51 yog?urt*
#52 red near/4 wine*
#53 #42 or #43 or #44 or #45 or #46 or #47 or #48 or #49 or #50 or #51 or #52
#54 (low or little or medium or moderate or less or decrease* or reduc* or restrict*) near/6 (intake or consumption or consume or eat*
or amount*)
#55 #53 and #54
#56 MeSH descriptor: [Diet, Mediterranean] this term only
#57 mediterranean near/3 diet*
#58 mediterranean near/6 food*
#59 mediterranean near/6 nutrition*
#60 mediterranean near/6 eat*
#61 (diet* or food* or nutrit* or eat*) near/2 (pattern* or habit*)
#62 MeSH descriptor: [Food Habits] this term only
#63 #56 or #57 or #58 or #59 or #60 or #61 or #62
#64 #41 or #55 or #63
#65 MeSH descriptor: [Cardiovascular Diseases] explode all trees
#66 cardio*
#67 cardia*
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#68 heart*
#69 coronary*
#70 angina*
#71 ventric*
#72 myocard*
#73 pericard*
#74 isch?em*
#75 MeSH descriptor: [Stroke] explode all trees
#76 stroke or stokes
#77 cerebrovasc*
#78 apoplexy
#79 brain near/2 accident*
#80 (brain* or cerebral or lacunar) near/2 infarct*
#81 MeSH descriptor: [Hypertension] explode all trees
#82 hypertensi*
#83 peripheral next arter* next disease*
#84 (high or increased or elevated) near/2 (blood next pressure)
#85 MeSH descriptor: [Hyperlipidemias] explode all trees
#86 hyperlipid*
#87 hyperlip?emia*
#88 hypercholesterol*
#89 hypercholester?emia*
#90 hyperlipoprotein?emia*
#91 hypertriglycerid?emia*
#92 emboli*
#93 arrhythmi*
#94 thrombo*
#95 atrial next fibrillat*
#96 tachycardi*
#97 endocardi*
#98 sick next sinus
#99 MeSH descriptor: [Diabetes Mellitus] explode all trees
#100 diabet*
#101 MeSH descriptor: [Hyperglycemia] explode all trees
#102 hyperglycemi*
#103 glucose near/2 intoleran*
#104 MeSH descriptor: [Insulin Resistance] explode all trees
#105 metabolic near/3 syndrome near/3 x
#106 metabolic next cardiovascular next syndrome
#107 dysmetabolic next syndrome next x
#108 insulin next resistan*
#109 MeSH descriptor: [Arteriosclerosis] explode all trees
#110 MeSH descriptor: [Cholesterol] explode all trees
#111 cholesterol
#112 “coronary risk factor*”
#113 MeSH descriptor: [Blood Pressure] this term only
#114 “blood pressure”
#115 #65 or #66 or #67 or #68 or #69 or #70 or #71 or #72 or #73 or #74
#116 #75 or #76 or #77 or #78 or #79 or #80 or #81 or #82 or #83 or #84
#117 #85 or #86 or #87 or #88 or #89 or #90 or #91 or #92 or #93 or #94
#118 #95 or #96 or #97 or #98 or #99 or #100
#119 #101 or #102 or #103 or #104 or #105 or #106 or #107 or #108 or #109 or #110 or #111 or #112 or #113 or #114
#120 #115 or #116 or #117 or #118 or #119
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#121 #64 and #120
MEDLINE Ovid (1946 to October week 1 2012)
The Cochrane sensitive maximising RCT filter has been applied to the search (Lefebvre C, Manheimer E, Glanville J. Chapter 6:
Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0
(updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org).
1. exp Fruit/
2. fruit*.tw.
3. exp Vegetables/
4. Vegetable Proteins/
5. vegetable*.tw.
6. exp Fabaceae/
7. fabaceae.tw.
8. bean*.tw.
9. legume*.tw.
10. Lycopersicon esculentum/
11. lycopersicon esculent*.tw.
12. tomato*.tw.
13. solanum lycopersicum.tw.
14. Nuts/
15. (nut or nuts).tw.
16. Bread/
17. bread*.tw.
18. exp Cereals/
19. cereal*.tw.
20. grain*.tw.
21. Solanum tuberosum/
22. solanum tuberosum.tw.
23. potato*.tw.
24. Seeds/
25. (seed or seeds).tw.
26. olive oil.tw.
27. Fatty Acids, Monounsaturated/
28. monounsaturated fat*.tw.
29. mono-unsaturated fat*.tw.
30. exp Seafood/
31. exp Fish Oils/
32. fish.tw.
33. seafood*.tw.
34. shellfish.tw.
35. or/1-34
36. ((high or more or increase* or elevat* or much or rais*) adj6 (intake or consumption or consume or eat* or amount*)).tw.
37. 35 and 36
38. exp Dairy Products/
39. exp Milk Proteins/
40. milk*.tw.
41. marg?rine*.tw.
42. butter*.tw.
43. dairy.tw.
44. cheese*.tw.
45. red meat*.tw.
46. processed meat*.tw.
47. yog?urt*.tw.
48. red wine*.tw.
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49. or/38-48
50. ((low or little or medium or moderate or less or decrease* or reduc* or restrict*) adj6 (intake or consumption or consume or eat*
or amount*)).tw.
51. 49 and 50
52. Diet, Mediterranean/
53. (mediterranean adj3 diet*).tw.
54. (mediterranean adj6 food*).tw.
55. (mediterranean adj6 nutrition*).tw.
56. (mediterranean adj6 eat*).tw.
57. ((diet* or food* or nutrit* or eat*) adj2 (pattern* or habit*)).tw.
58. Food Habits/
59. or/52-58
60. 37 or 51 or 59
61. exp Cardiovascular Diseases/
62. cardio*.tw.
63. cardia*.tw.
64. heart*.tw.
65. coronary*.tw.
66. angina*.tw.
67. ventric*.tw.
68. myocard*.tw.
69. pericard*.tw.
70. isch?em*.tw.
71. exp Stroke/
72. (stroke or stokes).tw.
73. cerebrovasc*.tw.
74. apoplexy.tw.
75. (brain adj2 accident*).tw.
76. ((brain* or cerebral or lacunar) adj2 infarct*).tw.
77. exp Hypertension/
78. hypertensi*.tw.
79. peripheral arter* disease*.tw.
80. ((high or increased or elevated) adj2 blood pressure).tw.
81. exp Hyperlipidemias/
82. hyperlipid*.tw.
83. hyperlip?emia*.tw.
84. hypercholesterol*.tw.
85. hypercholester?emia*.tw.
86. hyperlipoprotein?emia*.tw.
87. hypertriglycerid?emia*.tw.
88. isch?emi*.tw.
89. emboli*.tw.
90. arrhythmi*.tw.
91. thrombo*.tw.
92. atrial fibrillat*.tw.
93. tachycardi*.tw.
94. endocardi*.tw.
95. (sick adj sinus).tw.
96. exp Diabetes Mellitus/
97. diabet*.tw.
98. exp Hyperglycemia/
99. hyperglycemi*.tw.
100. (glucose adj2 intoleran*).tw.
48’Mediterranean’ dietary pattern for the primary prevention of cardiovascular disease (Review)
Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
101. exp Insulin Resistance/
102. (metabolic adj3 syndrome adj3 x).tw.
103. metabolic cardiovascular syndrome.tw.
104. dysmetabolic syndrome x.tw.
105. insulin resistan*.tw.
106. exp Arteriosclerosis/
107. exp Cholesterol/
108. cholesterol.tw.
109. “coronary risk factor*”.tw.
110. Blood Pressure/
111. blood pressure.tw.
112. or/61-111
113. 60 and 112
114. randomized controlled trial.pt.
115. controlled clinical trial.pt.
116. randomized.ab.
117. placebo.ab.
118. clinical trials as topic.sh.
119. randomly.ab.
120. trial.ti.
121. 114 or 115 or 116 or 117 or 118 or 119 or 120
122. exp animals/ not humans.sh.
123. 121 not 122
124. 113 and 123
EMBASE Ovid (1980 to 2012 week 41)
1. exp fruit/
2. fruit*.tw.
3. exp vegetable/
4. exp vegetable protein/
5. vegetable*.tw.
6. fabaceae.tw.
7. bean*.tw.
8. legume*.tw.
9. lycopersicon esculent*.tw.
10. tomato*.tw.
11. solanum lycopersicum.tw.
12. exp nut/
13. (nut or nuts).tw.
14. bread*.tw.
15. cereal*.tw.
16. grain*.tw.
17. exp grain/
18. solanum tuberosum.tw.
19. potato*.tw.
20. exp plant seed/
21. (seed or seeds).tw.
22. olive oil/
23. olive oil.tw.
24. monounsaturated fatty acid/
25. monounsaturated fat*.tw.
26. mono-unsaturated fat*.tw.
27. sea food/
28. fish oil/
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29. fish meat/
30. fish.tw.
31. seafood*.tw.
32. sea food*.tw.
33. shellfish.tw.
34. or/1-33
35. ((high or more or increase* or elevat* or much or rais*) adj6 (intake or consumption or consume or eat* or amount*)).tw.
36. 34 and 35
37. exp dairy product/
38. milk*.tw.
39. marg?rine*.tw.
40. butter*.tw.
41. dairy.tw.
42. cheese*.tw.
43. red meat*.tw.
44. processed meat*.tw.
45. exp red meat/
46. yog?urt*.tw.
47. red wine*.tw.
48. or/37-47
49. ((low or little or medium or moderate or less or decrease* or reduc* or restrict*) adj6 (intake or consumption or consume or eat*
or amount*)).tw.
50. 48 and 49
51. Mediterranean diet/
52. (mediterranean adj3 diet*).tw.
53. (mediterranean adj6 food*).tw.
54. (mediterranean adj6 nutrition*).tw.
55. (mediterranean adj6 eat*).tw.
56. ((diet* or food* or nutrit* or eat*) adj2 (pattern* or habit*)).tw.
57. eating habit/
58. or/51-57
59. 36 or 50 or 58
60. exp cardiovascular disease/
61. cardio*.tw.
62. cardia*.tw.
63. heart*.tw.
64. coronary*.tw.
65. angina*.tw.
66. ventric*.tw.
67. myocard*.tw.
68. pericard*.tw.
69. isch?em*.tw.
70. exp cerebrovascular disease/
71. (stroke or stokes).tw.
72. cerebrovasc*.tw.
73. apoplexy.tw.
74. (brain adj2 accident*).tw.
75. ((brain* or cerebral or lacunar) adj2 infarct*).tw.
76. exp hypertension/
77. hypertensi*.tw.
78. peripheral arter* disease*.tw.
79. ((high or increased or elevated) adj2 blood pressure).tw.
80. exp hyperlipidemia/
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81. hyperlipid*.tw.
82. hyperlip?emia*.tw.
83. hypercholesterol*.tw.
84. hypercholester?emia*.tw.
85. hyperlipoprotein?emia*.tw.
86. hypertriglycerid?emia*.tw.
87. emboli*.tw.
88. arrhythmi*.tw.
89. thrombo*.tw.
90. atrial fibrillat*.tw.
91. tachycardi*.tw.
92. endocardi*.tw.
93. (sick adj sinus).tw.
94. exp diabetes mellitus/
95. diabet*.tw.
96. diabet*.tw.
97. diabet*.tw.
98. hyperglycemia/
99. hyperglycemi*.tw.
100. (glucose adj2 intoleran*).tw.
101. insulin resistance/
102. (metabolic adj3 syndrome adj3 x).tw.
103. metabolic cardiovascular syndrome.tw.
104. dysmetabolic syndrome x.tw.
105. insulin resistan*.tw.
106. exp Arteriosclerosis/
107. exp Cholesterol/
108. cholesterol.tw.
109. “coronary risk factor*”.tw.
110. Blood Pressure/
111. blood pressure.tw.
112. or/60-111
113. random$.tw.
114. factorial$.tw.
115. crossover$.tw.
116. cross over$.tw.
117. cross-over$.tw.
118. placebo$.tw.
119. (doubl$ adj blind$).tw.
120. (singl$ adj blind$).tw.
121. assign$.tw.
122. allocat$.tw.
123. volunteer$.tw.
124. crossover procedure/
125. double blind procedure/
126. randomized controlled trial/
127. single blind procedure/
128. 113 or 114 or 115 or 116 or 117 or 118 or 119 or 120 or 121 or 122 or 123 or 124 or 125 or 126 or 127
129. (animal/ or nonhuman/) not human/
130. 128 not 129
131. 59 and 112 and 130
132. limit 131 to embase
Web of Science (1970 to 16 October 2012)
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#25 #24 AND #23
#24 TS=(random* or blind* or allocat* or assign* or trial* or placebo* or crossover* or cross-over*)
#23 #22 AND #10
#22 #21 OR #18 OR #15
#21 #20 OR #19
#20 TS= ((diet* or food* or nutrit* or eat*) SAME (pattern* or habit*))
#19 TS=((mediterranean) SAME (diet* or food* or nutrition* or eat*))
#18 #17 AND #16
#17 TS=((low or little or medium or moderate or less or decrease* or reduc* or restrict*) SAME (intake or consumption or consume
or eat* or amount*))
#16 TS=(milk* or marg?rine* or butter* or dairy or cheese* or “red meat*” or “processed meat*” or “red wine*”)
#15 #14 AND #13
#14 TS=((high or more or increase* or elevat* or much or rais*) SAME (intake or consumption or consume or eat* or amount*))
#13 #12 OR #11
#12 TS=(“solamun tuberosum” or potato* or seed or seeds or “olive oil” or “monounsaturated fat*” or “mono-unsaturated fat*” or fish
or seafood* or shellfish)
#11 TS=(fruit* or vegetable* or fabaceae or bean* or legume* or “lycopersicon esculent*” or tomato* or “solanum lycopersicum” or
nut or nuts or bread* or cereal* or grain*)
#10 #9 OR #8 OR #7 OR #6 OR #5 OR #4 OR #3 OR #2 OR #1
#9 TS=(arteriosclerosis or cholesterol or “coronary risk factor*” or “blood pressure”)
#8 TS=diabet*
#7 TS=(hyperlipid* or hyperlip?emia* or hypercholesterol* or hypercholester?emia* or hyperlipoprotein?emia* or hypertriglycerid?
emia*)
#6 TS=(“high blood pressure”)
#5 TS=(hypertensi* or “peripheral arter* disease*”)
#4 TS=(stroke or strokes or cerebrovasc* or cerebral or apoplexy or (brain SAME accident*) or (brain SAME infarct*))
#3 TS=(“artrial fibrillat*” or tachycardi* or endocardi*)
#2 TS=(pericard* or isch?em* or emboli* or arrhythmi* or thrombo*)
#1 TS=(cardio* or cardia* or heart* or coronary* or angina* or ventric* or myocard*)
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We intended to look at studies examining dietary advice to follow a Mediterranean-style diet separately from studies examining the
provision of foods, but for all studies that met our inclusion criteria the intervention was dietary advice. It was also our intention to
stratify results according to the number of components constituting theMediterranean dietary pattern and the intensity and duration of
the intervention. However, there were insufficient trials that met the inclusion criteria to perform these analyses. Similarly, we planned
to stratify results by general population and high-risk participants, follow-up period, age and gender to determine their impact on effect
estimates but there are insufficient trials to date to do this.
We also intended to examine the effect of alcohol consumption and other potential adverse effects of the Mediterranean diet in our
analyses but this information was not reported in the few trials that met the inclusion criteria.
In the protocol, we stated that we would exclude studies where loss to follow-up exceeded 20%. We have relaxed this inclusion criterion
and have instead performed sensitivity analyses excluding these studies to examine the impact on pooled effect estimates.
We also intended to focus on studies with follow-up of six months or more but studies with this length of follow-up were lacking and
so studies with follow-up of three months or more were included.
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